QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
|
||
(Address of principal executive offices) |
(Zip Code) |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||
Emerging growth company |
Title of Each Class |
Trading Symbol |
Name of each exchange on which registered | ||
Page |
||||||
3 |
||||||
3 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
7 |
||||||
8 |
||||||
65 |
||||||
125 |
||||||
125 |
||||||
126 |
||||||
126 |
||||||
126 |
||||||
127 |
||||||
128 |
March 31, 2022 |
December 31, 2021 |
|||||||
(Unaudited) |
||||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available-for-sale, at fair value (amortized cost of $ |
$ | $ | ||||||
Equity securities, at fair value |
||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $ |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Commercial mortgage loans, net |
||||||||
Policy loans |
||||||||
Limited partnerships |
||||||||
Other invested assets |
||||||||
|
|
|
|
|||||
Total investments |
||||||||
Cash, cash equivalents and restricted cash |
||||||||
Accrued investment income |
||||||||
Deferred acquisition costs |
||||||||
Intangible assets |
||||||||
Reinsurance recoverable |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Reinsurance recoverable, net |
||||||||
Other assets |
||||||||
Deferred tax asset |
||||||||
Separate account assets |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities and equity |
||||||||
Liabilities: |
||||||||
Future policy benefits |
$ | $ | ||||||
Policyholder account balances |
||||||||
Liability for policy and contract claims |
||||||||
Unearned premiums |
||||||||
Other liabilities |
||||||||
Long-term borrowings |
||||||||
Separate account liabilities |
||||||||
Liabilities related to discontinued operations |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies |
||||||||
Equity: |
||||||||
Class A common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive income (loss) |
||||||||
Retained earnings |
||||||||
Treasury stock, at cost ( |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Genworth Financial, Inc.’s stockholders’ equity |
||||||||
Noncontrolling interests |
||||||||
|
|
|
|
|||||
Total equity |
||||||||
|
|
|
|
|||||
Total liabilities and equity |
$ | $ | ||||||
|
|
|
|
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
Revenues: |
||||||||
Premiums |
$ | $ | ||||||
Net investment income |
||||||||
Net investment gains (losses) |
||||||||
Policy fees and other income |
||||||||
|
|
|
|
|||||
Total revenues |
||||||||
|
|
|
|
|||||
Benefits and expenses: |
||||||||
Benefits and other changes in policy reserves |
||||||||
Interest credited |
||||||||
Acquisition and operating expenses, net of deferrals |
||||||||
Amortization of deferred acquisition costs and intangibles |
||||||||
Interest expense |
||||||||
|
|
|
|
|||||
Total benefits and expenses |
||||||||
|
|
|
|
|||||
Income from continuing operations before income taxes |
||||||||
Provision for income taxes |
||||||||
|
|
|
|
|||||
Income from continuing operations |
||||||||
Income (loss) from discontinued operations, net of taxes |
( |
) | ||||||
|
|
|
|
|||||
Net income |
||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
||||||||
|
|
|
|
|||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
|
|
|
|
|||||
Net income available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
( |
) | ||||||
|
|
|
|
|||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
|
|
|
|
|||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | $ | ||||||
|
|
|
|
|||||
Diluted |
$ | $ | ||||||
|
|
|
|
|||||
Net income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | $ | ||||||
|
|
|
|
|||||
Diluted |
$ | $ | ||||||
|
|
|
|
|||||
Weighted-average common shares outstanding: |
||||||||
Basic |
||||||||
|
|
|
|
|||||
Diluted |
||||||||
|
|
|
|
|||||
Three months ended |
||||||||
March 31, |
||||||||
2022 |
2021 |
|||||||
Net income |
$ | $ | ||||||
Other comprehensive income (loss), net of taxes: |
||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
( |
) | ( |
) | ||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
||||||||
Derivatives qualifying as hedges |
( |
) | ( |
) | ||||
Foreign currency translation and other adjustments |
( |
) | ||||||
|
|
|
|
|||||
Total other comprehensive income (loss) |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total comprehensive loss |
( |
) | ( |
) | ||||
Less: comprehensive income (loss) attributable to noncontrolling interests |
( |
) | ||||||
|
|
|
|
|||||
Total comprehensive loss available to Genworth Financial, Inc.’s common stockholders |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
Three months ended March 31, 2022 |
||||||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Genworth |
||||||||||||||||||||||||||||||||
Accumulated |
Financial, |
|||||||||||||||||||||||||||||||
Additional |
other |
Treasury |
Inc.’s |
|||||||||||||||||||||||||||||
Common |
paid-in |
comprehensive |
Retained |
stock, at |
stockholders’ |
Noncontrolling |
Total |
|||||||||||||||||||||||||
stock |
capital |
income (loss) |
earnings |
cost |
equity |
interests |
equity |
|||||||||||||||||||||||||
Balances as of December 31, 2021 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Other comprehensive loss, net of taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
Total comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Balances as of March 31, 2022 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Three months ended March 31, 2021 |
||||||||||||||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||
Genworth |
||||||||||||||||||||||||||||||||
Accumulated |
Financial, |
|||||||||||||||||||||||||||||||
Additional |
other |
Treasury |
Inc.’s |
|||||||||||||||||||||||||||||
Common |
paid-in |
comprehensive |
Retained |
stock, at |
stockholders’ |
Noncontrolling |
Total |
|||||||||||||||||||||||||
stock |
capital |
income (loss) |
earnings |
cost |
equity |
interests |
equity |
|||||||||||||||||||||||||
Balances as of December 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Sale of business that included noncontrolling interests |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of taxes |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Total comprehensive income (loss) |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
||||||||||||||||||||||||||||||||
Balances as of March 31, 2021 |
$ | $ | $ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||||
Three months ended |
||||||||
March 31, |
||||||||
2022 |
2021 |
|||||||
Cash flows from (used by) operating activities: |
||||||||
Net income |
$ | $ | ||||||
Less (income) loss from discontinued operations, net of taxes |
( |
) | ||||||
Adjustments to reconcile net income to net cash used by operating activities: |
||||||||
Amortization of fixed maturity securities discounts and premiums |
( |
) | ( |
) | ||||
Net investment (gains) losses |
( |
) | ( |
) | ||||
Charges assessed to policyholders |
( |
) | ( |
) | ||||
Acquisition costs deferred |
( |
) | ( |
) | ||||
Amortization of deferred acquisition costs and intangibles |
||||||||
Deferred income taxes |
||||||||
Derivative instruments, limited partnerships and other |
( |
) | ( |
) | ||||
Stock-based compensation expense |
||||||||
Change in certain assets and liabilities: |
||||||||
Accrued investment income and other assets |
( |
) | ( |
) | ||||
Insurance reserves |
||||||||
Current tax liabilities |
( |
) | ||||||
Other liabilities, policy and contract claims and other policy-related balances |
( |
) | ( |
) | ||||
Cash used by operating activities — discontinued operations |
( |
) | ( |
) | ||||
Net cash used by operating activities |
( |
) | ( |
) | ||||
Cash flows from (used by) investing activities: |
||||||||
Proceeds from maturities and repayments of investments: |
||||||||
Fixed maturity securities |
||||||||
Commercial mortgage loans |
||||||||
Limited partnerships and other invested assets |
||||||||
Proceeds from sales of investments: |
||||||||
Fixed maturity and equity securities |
||||||||
Purchases and originations of investments: |
||||||||
Fixed maturity and equity securities |
( |
) | ( |
) | ||||
Commercial mortgage loans |
( |
) | ( |
) | ||||
Limited partnerships and other invested assets |
( |
) | ( |
) | ||||
Short-term investments, net |
( |
) | ||||||
Policy loans, net |
||||||||
Proceeds from sale of business, net of cash transferred |
||||||||
Cash used by investing activities — discontinued operations |
( |
) | ||||||
Net cash from investing activities |
||||||||
Cash flows from (used by) financing activities: |
||||||||
Deposits to universal life and investment contracts |
||||||||
Withdrawals from universal life and investment contracts |
( |
) | ( |
) | ||||
Repayment and repurchase of long-term debt |
( |
) | ( |
) | ||||
Other, net |
||||||||
Net cash used by financing activities |
( |
) | ( |
) | ||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $ |
||||||||
Net change in cash, cash equivalents and restricted cash |
( |
) | ( |
) | ||||
Cash, cash equivalents and restricted cash at beginning of period |
||||||||
Cash, cash equivalents and restricted cash at end of period |
||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | $ | ||||||
• | Enact. |
• | U.S. Life Insurance. |
• | Runoff. |
• |
assumptions will no longer be locked-in at contract inception and all cash flow assumptions used to estimate the liability for future policy benefits (except the discount rate) will be reviewed at least annually in the same period each year or more frequently if actual experience indicates a change is required. Changes will be recorded in net income (loss) using a retrospective approach with a cumulative catch-up adjustment by recalculating the net premium ratio (which will be capped at 100%) using actual historical and updated future cash flow assumptions; |
• |
the discount rate used to determine the liability for future policy benefits will be a current upper-medium grade (low credit risk) fixed-income instrument yield, which is generally interpreted to mean a single-A rated bond rate for the same duration, and is required to be reviewed quarterly, with changes in the discount rate recorded in other comprehensive income (loss); |
• |
the provision for adverse deviation and the premium deficiency test will be eliminated; |
• |
market risk benefits associated with deposit-type contracts will be measured at fair value with changes related to instrument-specific credit risk recorded in other comprehensive income (loss) and remaining changes recorded in net income (loss); |
• |
the amortization method for DAC will generally be on a straight-line basis over the expected contract term; and |
• |
disclosures will be greatly expanded to include significant assumptions and product liability rollforwards. |
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions, except per share amounts) |
2022 |
2021 |
||||||
Weighted-average shares used in basic earnings per share calculations |
||||||||
Potentially dilutive securities: |
||||||||
Stock options, restricted stock units and other equity-based compensation |
||||||||
|
|
|
|
|||||
Weighted-average shares used in diluted earnings per share calculations |
||||||||
|
|
|
|
|||||
Income from continuing operations: |
||||||||
Income from continuing operations |
$ | $ | ||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
|
|
|
|
|||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
|
|
|
|
|||||
Basic per share |
$ | $ | ||||||
|
|
|
|
|||||
Diluted per share |
$ | $ | ||||||
|
|
|
|
|||||
Income (loss) from discontinued operations: |
||||||||
Income (loss) from discontinued operations, net of taxes |
$ | ( |
) | $ | ||||
Less: net income (loss) from discontinued operations attributable to noncontrolling interests |
||||||||
|
|
|
|
|||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
$ | ( |
) | $ | ||||
|
|
|
|
|||||
Basic per share |
$ | $ | ||||||
|
|
|
|
|||||
Diluted per share |
$ | $ | ||||||
|
|
|
|
|||||
Net income: |
||||||||
Income from continuing operations |
$ | $ | ||||||
Income (loss) from discontinued operations, net of taxes |
( |
) | ||||||
|
|
|
|
|||||
Net income |
||||||||
Less: net income attributable to noncontrolling interests |
||||||||
|
|
|
|
|||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
|
|
|
|
|||||
Basic per share (1) |
$ | $ | ||||||
|
|
|
|
|||||
Diluted per share (1) |
$ | $ | ||||||
|
|
|
|
(1) |
May not total due to whole number calculation. |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Fixed maturity securities—taxable |
$ | $ | ||||||
Fixed maturity securities—non-taxable |
||||||||
Equity securities |
||||||||
Commercial mortgage loans |
||||||||
Policy loans |
||||||||
Limited partnerships |
||||||||
Other invested assets |
||||||||
|
|
|
|
|||||
Gross investment income before expenses and fees |
||||||||
Expenses and fees |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net investment income |
$ | $ | ||||||
|
|
|
|
Three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Realized investment gains (losses): |
||||||||
Available-for-sale fixed maturity securities: |
||||||||
Realized gains |
$ | $ | ||||||
Realized losses |
( |
) | ( |
) | ||||
Net realized gains (losses) on available-for-sale fixed maturity securities |
( |
) | ||||||
Net realized gains (losses) on equity securities sold |
( |
) | ||||||
Net realized gains (losses) on limited partnerships |
||||||||
Total net realized investment gains (losses) |
( |
) | ||||||
Net change in allowance for credit losses on available-for-sale fixed maturity securities |
( |
) | ||||||
Write-down of available-for-sale fixed maturity securities (1) |
( |
) | ( |
) | ||||
Net unrealized gains (losses) on equity securities still held |
( |
) | ( |
) | ||||
Net unrealized gains (losses) on limited partnerships |
||||||||
Commercial mortgage loans |
( |
) | ||||||
Derivative instruments (2) |
||||||||
Other |
||||||||
Net investment gains (losses) |
$ | $ | ||||||
(1) |
Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. |
(2) |
See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). |
(Amounts in millions) |
Beginning balance |
Increase from securities without allowance in previous periods |
Increase (decrease) from securities with allowance in previous periods |
Securities sold |
Decrease due to change in intent or requirement to sell |
Write-offs |
Recoveries |
Ending balance |
||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||
Non-U.S. corporate |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||
Total available-for-sale fixed maturity securities |
$ | $ | $ | $ | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||||
(Amounts in millions) |
March 31, 2022 |
December 31, 2021 |
||||||
Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) |
$ | $ | ||||||
Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) |
||||||||
Adjustments to DAC, present value of future profits, sales inducements, benefit reserves and policyholder contract balances |
( |
) | ( |
) | ||||
Income taxes, net |
( |
) | ( |
) | ||||
Net unrealized investment gains (losses) |
||||||||
Less: net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | ||||||
Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. |
$ | $ | ||||||
(1) |
Excludes foreign exchange. |
(Amounts in millions) |
2022 |
2021 |
||||||
Beginning balance |
$ | $ | ||||||
Unrealized gains (losses) arising during the period: |
||||||||
Unrealized gains (losses) on fixed maturity securities |
( |
) | ( |
) | ||||
Adjustment to DAC |
( |
) | ||||||
Adjustment to present value of future profits |
||||||||
Adjustment to sales inducements |
||||||||
Adjustment to benefit reserves and policyholder contract balances |
||||||||
Provision for income taxes |
||||||||
Change in unrealized gains (losses) on investment securities |
( |
) | ( |
) | ||||
Reclassification adjustments to net investment (gains) losses, net of taxes of $( |
( |
) | ||||||
Change in net unrealized investment gains (losses) |
( |
) | ( |
) | ||||
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | ( |
) | ||||
Ending balance |
$ | $ | ||||||
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total non-U.S. corporate |
( |
) | ||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||
Total available-for-sale fixed maturity securities |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
( |
) | ||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||
Other |
( |
) | ||||||||||||||||||
Total non-U.S. corporate |
( |
) | ||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||
Total available-for-sale fixed maturity securities |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
State and political subdivisions |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
20%-50% Below cost |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Subtotal, U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Subtotal, non-U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for corporate securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
20%-50% Below cost |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for fixed maturity securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Subtotal, non-U.S. corporate securities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for corporate securities in an unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
(Amounts in millions) |
Amortized cost or cost |
Fair value |
||||||
Due one year or less |
$ | $ | ||||||
Due after one year through five years |
||||||||
Due after five years through ten years |
||||||||
Due after ten years |
||||||||
Subtotal |
||||||||
Residential mortgage-backed |
||||||||
Commercial mortgage-backed |
||||||||
Other asset-backed |
||||||||
Total |
$ | $ | ||||||
March 31, 2022 |
December 31, 2021 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Property type: |
||||||||||||||||
Retail |
$ | % | $ | % | ||||||||||||
Office |
||||||||||||||||
Industrial |
||||||||||||||||
Apartments |
||||||||||||||||
Mixed use |
||||||||||||||||
Other |
||||||||||||||||
Subtotal |
% | % | ||||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Total |
$ | $ | ||||||||||||||
March 31, 2022 |
December 31, 2021 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Geographic region: |
||||||||||||||||
South Atlantic |
$ | % | $ | % | ||||||||||||
Pacific |
||||||||||||||||
Middle Atlantic |
||||||||||||||||
Mountain |
||||||||||||||||
West South Central |
||||||||||||||||
West North Central |
||||||||||||||||
East North Central |
||||||||||||||||
New England |
||||||||||||||||
East South Central |
||||||||||||||||
Subtotal |
% | % | ||||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Total |
$ | $ | ||||||||||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Allowance for credit losses: |
||||||||
Beginning balance |
$ | $ | ||||||
Provision |
( |
) | ||||||
Write-offs |
||||||||
Recoveries |
||||||||
Ending balance |
$ | $ | ||||||
(Amounts in millions) |
2022 |
2021 |
2020 |
2019 |
2018 |
2017 and prior |
Total |
|||||||||||||||||||||
Debt-to-value: |
||||||||||||||||||||||||||||
0% - 50% |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
51% - 60% |
||||||||||||||||||||||||||||
61% - 75% |
||||||||||||||||||||||||||||
76% - 100% |
||||||||||||||||||||||||||||
Greater than 100% |
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Debt service coverage ratio: |
||||||||||||||||||||||||||||
Less than 1.00 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
1.00 - 1.25 |
||||||||||||||||||||||||||||
1.26 - 1.50 |
||||||||||||||||||||||||||||
1.51 - 2.00 |
||||||||||||||||||||||||||||
Greater than 2.00 |
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
Derivative assets |
Derivative liabilities |
|||||||||||||||||||||||
Fair value |
Fair value |
|||||||||||||||||||||||
(Amounts in millions) |
Balance sheet classification |
March 31, 2022 |
December 31, 2021 |
Balance sheet classification |
March 31, 2022 |
December 31, 2021 |
||||||||||||||||||
Derivatives designated as |
||||||||||||||||||||||||
hedges |
||||||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||||||
Interest rate swaps |
Other invested assets | $ | $ | Other liabilities | $ | $ | ||||||||||||||||||
Foreign currency swaps |
Other invested assets | Other liabilities | ||||||||||||||||||||||
Total cash flow hedges |
||||||||||||||||||||||||
Total derivatives designated as hedges |
||||||||||||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||||||
Equity index options |
Other invested assets | Other liabilities | ||||||||||||||||||||||
Financial futures |
Other invested assets | Other liabilities | ||||||||||||||||||||||
Other foreign currency contracts |
Other invested assets | Other liabilities | ||||||||||||||||||||||
GMWB embedded derivatives |
Reinsurance recoverable (1) |
|
Policyholder account balances (2) |
|
||||||||||||||||||||
Fixed index annuity embedded derivatives |
Other assets | Policyholder account balances (3) |
|
|||||||||||||||||||||
Indexed universal life embedded derivatives |
Reinsurance recoverable |
|
Policyholder account balances (4) |
|
||||||||||||||||||||
Total derivatives not designated as hedges |
||||||||||||||||||||||||
Total derivatives |
$ | $ | $ | $ | ||||||||||||||||||||
(1) |
Represents embedded derivatives associated with the reinsured portion of our guaranteed minimum withdrawal benefits (“GMWB”) liabilities. |
(2) |
Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
(3) |
Represents the embedded derivatives associated with our fixed index annuity liabilities. |
(4) |
Represents the embedded derivatives associated with our indexed universal life liabilities. |
(Notional in millions) |
Measurement |
December 31, 2021 |
Additions |
Maturities/ terminations |
March 31, 2022 |
|||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Notional | $ | $ | $ | ( |
) | $ | |||||||||||||
Foreign currency swaps |
Notional | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total cash flow hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives designated as hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Equity index options |
Notional | ( |
) | |||||||||||||||||
Financial futures |
Notional | ( |
) | |||||||||||||||||
Other foreign currency contracts |
Notional | ( |
) | |||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives not designated as hedges |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives |
$ | $ | $ | ( |
) | $ | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
(Number of policies) |
Measurement |
December 31, 2021 |
Additions |
Maturities/ terminations |
March 31, 2022 |
|||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
GMWB embedded derivatives |
Policies | ( |
) | |||||||||||||||||
Fixed index annuity embedded derivatives |
Policies | ( |
) | |||||||||||||||||
Indexed universal life embedded derivatives |
Policies | ( |
) |
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income from OCI |
Classification of gain (loss) reclassified into net income |
Gain (loss) recognized in net income |
Classification of gain (loss) recognized in net income |
|||||||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | Net investment income |
|
$ | Net investment gains (losses) |
| |||||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) |
|
Net investment gains (losses) |
| ||||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense |
|
Net investment gains (losses) |
| ||||||||||||||
Foreign currency swaps |
( |
) | Net investment income |
|
Net investment gains (losses) |
| ||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Total |
$ | ( |
) | $ | $ | |||||||||||||||
|
|
|
|
|
|
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income from OCI |
Classification of gain (loss) reclassified into net income |
Gain (loss) recognized in net income |
Classification of gain (loss) recognized in net income | |||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | Net investment income | $ | Net investment gains (losses) | |||||||||
Interest rate swaps hedging liabilities |
Interest expense | Net investment gains (losses) | ||||||||||||||
Foreign currency swaps |
( |
) | Net investment income | Net investment gains (losses) | ||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | ( |
) | $ | $ | |||||||||||
|
|
|
|
|
|
Three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Derivatives qualifying as effective accounting hedges as of January 1 |
$ | $ | ||||||
Current period increases (decreases) in fair value, net of deferred taxes of $ |
( |
) | ( |
) | ||||
Reclassification to net (income), net of deferred taxes of $ |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Derivatives qualifying as effective accounting hedges as of March 31 |
$ | $ | ||||||
|
|
|
|
Three months ended March 31, |
Classification of gain (loss) recognized in net income | |||||||||
(Amounts in millions) |
2022 |
2021 |
||||||||
Interest rate swaps |
$ | $ | Net investment gains (losses) | |||||||
Equity index options |
( |
) | Net investment gains (losses) | |||||||
Financial futures |
( |
) | ( |
) | Net investment gains (losses) | |||||
GMWB embedded derivatives |
Net investment gains (losses) | |||||||||
Fixed index annuity embedded derivatives |
( |
) | Net investment gains (losses) | |||||||
Indexed universal life embedded derivatives |
Net investment gains (losses) | |||||||||
|
|
|
|
|||||||
Total derivatives not designated as hedges |
$ | $ | ||||||||
|
|
|
|
March 31, 2022 |
December 31, 2021 |
|||||||||||||||||||||||
(Amounts in millions) |
Derivative assets (1) |
Derivative liabilities (1) |
Net derivatives |
Derivative assets (1) |
Derivative liabilities (1) |
Net derivatives |
||||||||||||||||||
Amounts presented in the balance sheet: |
||||||||||||||||||||||||
Gross amounts recognized |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Gross amounts offset in the balance sheet |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net amounts presented in the balance sheet |
||||||||||||||||||||||||
Gross amounts not offset in the balance sheet: |
||||||||||||||||||||||||
Financial instruments (2) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral received |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral pledged |
( |
) | ( |
) | ||||||||||||||||||||
Over collateralization |
( |
) | ( |
) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net amount |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Included $ |
(2) |
Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. |
(6) |
Fair Value of Financial Instruments |
• | Third-party pricing services: |
(Amounts in millions) |
Fair value |
Primary methodologies |
Significant inputs | |||||
U.S. government, agencies and government-sponsored enterprises |
$ |
|||||||
State and political subdivisions |
$ |
|||||||
Non-U.S. government |
$ |
|||||||
U.S. corporate |
$ |
|||||||
Non-U.S. corporate |
$ |
|||||||
Residential mortgage-backed |
$ |
|||||||
|
|
|
|
|
|
|
|
|
Commercial mortgage-backed |
$ |
|||||||
Other asset-backed |
$ |
• | Internal models: |
• | Broker quotes: |
• | Internal models: |
March 31, 2022 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total U.S. corporate |
||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total non-U.S. corporate |
||||||||||||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
||||||||||||||||||||
Other asset-backed |
||||||||||||||||||||
Total fixed maturity securities |
||||||||||||||||||||
Equity securities |
||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
||||||||||||||||||||
Foreign currency swaps |
||||||||||||||||||||
Equity index options |
||||||||||||||||||||
Total derivative assets |
||||||||||||||||||||
Short-term investments |
||||||||||||||||||||
Total other invested assets |
||||||||||||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||
Separate account assets |
||||||||||||||||||||
Total assets |
$ | $ | $ | $ | $ | |||||||||||||||
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
December 31, 2021 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | |||||||||||||||
State and political subdivisions |
||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total U.S. corporate |
||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||
Transportation |
||||||||||||||||||||
Other |
||||||||||||||||||||
Total non-U.S. corporate |
||||||||||||||||||||
Residential mortgage-backed |
||||||||||||||||||||
Commercial mortgage-backed |
||||||||||||||||||||
Other asset-backed |
||||||||||||||||||||
Total fixed maturity securities |
||||||||||||||||||||
Equity securities |
||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
||||||||||||||||||||
Foreign currency swaps |
||||||||||||||||||||
Equity index options |
||||||||||||||||||||
Other foreign currency contracts |
||||||||||||||||||||
Total derivative assets |
||||||||||||||||||||
Short-term investments |
||||||||||||||||||||
Total other invested assets |
||||||||||||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||
Separate account assets |
||||||||||||||||||||
Total assets |
$ | $ | $ | $ | $ | |||||||||||||||
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
Beginning balance as of January 1, 2022 |
Total realized and unrealized gains (losses) |
Ending balance as of March 31, 2022 |
Total gains (losses) attributable to assets still held |
|||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net income |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1 ) |
Included in net income |
Included in OCI |
||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | $ | ( |
) | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||||||||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total derivative assets |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total other invested assets |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
Beginning balance as of January 1, 2021 |
Total realized and unrealized gains (losses) |
Ending balance as of March 31, 2021 |
Total gains (losses) attributable to assets still held |
|||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net income |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1) |
Included in net income |
Included in OCI |
||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
||||||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Limited partnerships |
||||||||||||||||||||||||||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total derivative assets |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total other invested assets |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Reinsurance recoverable (2) |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
(Amounts in millions) |
2022 |
2021 |
||||||
Total realized and unrealized gains (losses) included in net income: |
||||||||
Net investment income |
$ | $ | ||||||
Net investment gains (losses) |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Net gains (losses) included in net income attributable to assets still held: |
||||||||
Net investment income |
$ | $ | ||||||
Net investment gains (losses) |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
(Amounts in millions) |
Valuation technique |
Fair value |
Unobservable input |
Range |
Weighted-average (1) | |||||||
Fixed maturity securities: |
||||||||||||
U.S. corporate: |
||||||||||||
Utilities |
$ |
Credit spreads |
||||||||||
Energy |
Credit spreads |
|||||||||||
Finance and insurance |
Credit spreads |
|||||||||||
Consumer—non-cyclical |
Credit spreads |
|||||||||||
Technology and communications |
Credit spreads |
|||||||||||
Industrial |
Credit spreads |
|||||||||||
Capital goods |
Credit spreads |
|||||||||||
Consumer—cyclical |
Credit spreads |
|||||||||||
Transportation |
Credit spreads |
|||||||||||
Other |
Credit spreads |
|||||||||||
Total U.S. corporate |
$ |
Credit spreads |
||||||||||
Non-U.S. corporate: |
||||||||||||
Utilities |
$ |
Credit spreads |
||||||||||
Energy |
Credit spreads |
|||||||||||
Finance and insurance |
Credit spreads |
|||||||||||
Consumer—non-cyclical |
Credit spreads |
|||||||||||
Technology and communications |
Credit spreads |
|||||||||||
Industrial |
Credit spreads |
|||||||||||
Capital goods |
Credit spreads |
|||||||||||
Consumer—cyclical |
Credit spreads |
|||||||||||
Transportation |
Credit spreads |
|||||||||||
Other |
Credit spreads |
|||||||||||
Total non-U.S. corporate |
$ |
Credit spreads |
||||||||||
Derivative assets: |
||||||||||||
Equity index options |
$ |
Equity index volatility |
(1) |
Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets. |
March 31, 2022 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | ||||||||||||
Fixed index annuity embedded derivatives |
||||||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
Total policyholder account balances |
||||||||||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
Foreign currency swaps |
||||||||||||||||
Total derivative liabilities |
||||||||||||||||
Total liabilities |
$ | $ | $ | $ | ||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
December 31, 2021 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | ||||||||||||
Fixed index annuity embedded derivatives |
||||||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
Total policyholder account balances |
||||||||||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
Total derivative liabilities |
||||||||||||||||
Total liabilities |
$ | $ | $ | $ | ||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of January 1, 2022 |
Total realized and unrealized (gains) losses |
Ending balance as of March 31, 2022 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 |
Transfer out of Level 3 |
Included in net (income) |
Included in OCI |
||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | ( |
) | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | ( |
) | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of January 1, 2021 |
Total realized and unrealized (gains) losses |
Ending balance as of March 31, 2021 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 |
Transfer out of Level 3 |
Included in net (income) |
Included in OCI |
||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | ( |
) | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||||
Fixed index annuity embedded derivatives |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | ( |
) | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
(Amounts in millions) |
2022 |
2021 |
||||||
Total realized and unrealized (gains) losses included in net (income): |
||||||||
Net investment income |
$ | $ | ||||||
Net investment (gains) losses |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Total (gains) losses included in net (income) attributable to liabilities still held: |
||||||||
Net investment income |
$ | $ | ||||||
Net investment (gains) losses |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
(Amounts in millions) |
Valuation technique |
Fair value |
Unobservable input |
Range |
Weighted-average (1) |
|||||||||||||||
Policyholder account balances: |
||||||||||||||||||||
Withdrawal utilization rate |
||||||||||||||||||||
Lapse rate |
||||||||||||||||||||
|
Non-performance risk (credit spreads) |
|
||||||||||||||||||
GMWB embedded derivatives (2) |
Stochastic cash flow model |
$ |
Equity index volatility |
|||||||||||||||||
Fixed index annuity embedded derivatives |
Option budget method |
$ |
Expected future interest credited |
|||||||||||||||||
Indexed universal life embedded derivatives |
Option budget method |
$ |
Expected future interest credited |
(1) |
Unobservable inputs weighted by the policyholder account balances associated with the instrument. |
(2) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs. |
March 31, 2022 |
||||||||||||||||||||||||
Notional amount |
Carrying amount |
Fair value |
||||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Commercial mortgage loans, net |
(1) |
$ | $ | $ | $ | $ | ||||||||||||||||||
Bank loan investments |
(1) |
|||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Long-term borrowings |
(1) |
|||||||||||||||||||||||
Investment contracts |
(1) |
|||||||||||||||||||||||
Other firm commitments: |
||||||||||||||||||||||||
Commitments to fund bank loan investments |
||||||||||||||||||||||||
Ordinary course of business lending commitments |
(1) |
These financial instruments do not have notional amounts. |
December 31, 2021 |
||||||||||||||||||||||||
Notional amount |
Carrying amount |
Fair value |
||||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Commercial mortgage loans, net |
(1) |
$ | $ | $ | $ | $ | ||||||||||||||||||
Bank loan investments |
(1) |
|||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Long-term borrowings |
(1) |
|||||||||||||||||||||||
Investment contracts |
(1) |
|||||||||||||||||||||||
Other firm commitments: |
||||||||||||||||||||||||
Commitments to fund bank loan investments |
||||||||||||||||||||||||
Ordinary course of business lending commitments |
(1) |
These financial instruments do not have notional amounts. |
March 31, 2022 |
December 31, 2021 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
Commitments to fund |
Carrying value |
Commitments to fund |
||||||||||||
Limited partnerships accounted for at NAV: |
||||||||||||||||
Private equity funds (1) |
$ | $ | $ | $ | ||||||||||||
Real estate funds (2) |
||||||||||||||||
Infrastructure funds (3) |
||||||||||||||||
Total limited partnerships accounted for at NAV |
||||||||||||||||
Limited partnerships accounted for at fair value |
||||||||||||||||
Limited partnerships accounted for under equity method of accounting |
||||||||||||||||
Low-income housing tax credits (4) |
||||||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
(1) |
This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America. |
(2) |
This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments. |
(3) |
This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally. |
(4) |
Relates to limited partnership investments that invest in affordable housing projects that qualify for the Low-Income Housing Tax Credit and are accounted for using the proportional amortization method. |
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Beginning balance |
$ | $ | ||||||
Less reinsurance recoverables |
( |
) | ( |
) | ||||
Net beginning balance |
||||||||
Incurred related to insured events of: |
||||||||
Current year |
||||||||
Prior years |
( |
) | ( |
) | ||||
Total incurred |
||||||||
Paid related to insured events of: |
||||||||
Current year |
( |
) | ( |
) | ||||
Prior years |
( |
) | ( |
) | ||||
Total paid |
( |
) | ( |
) | ||||
Interest on liability for policy and contract claims |
||||||||
Net ending balance |
||||||||
Add reinsurance recoverables |
||||||||
Ending balance |
$ | $ | ||||||
(Amounts in millions) |
March 31, 2022 |
December 31, 2021 |
||||||
Genworth Holdings (1) |
||||||||
$ | $ | |||||||
Floating Rate Junior Subordinated Notes, due |
||||||||
Subtotal |
||||||||
Bond consent fees |
( |
) | ( |
) | ||||
Deferred borrowing charges |
( |
) | ( |
) | ||||
Total Genworth Holdings |
||||||||
Enact Holdings |
||||||||
(2) |
||||||||
Deferred borrowing charges |
( |
) | ( |
) | ||||
Total Enact Holdings |
||||||||
Total |
$ | $ | ||||||
(1) |
Genworth Holdings has the option to redeem all or a portion of the senior notes at any time with notice to the noteholders at a price equal to the greater of |
(2) |
Senior notes issued by Enact Holdings, our majority-owned indirect subsidiary, who has the option to redeem the notes in whole or in part at any time prior to |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
Statutory U.S. federal income tax rate |
% | % | ||||||
Increase in rate resulting from: |
||||||||
Tax on income from terminated swaps |
||||||||
Other, net |
||||||||
Effective rate |
% | % | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Revenues: |
||||||||
Enact segment |
$ | $ | ||||||
U.S. Life Insurance segment: |
||||||||
Long-term care insurance |
||||||||
Life insurance |
||||||||
Fixed annuities |
||||||||
U.S. Life Insurance segment |
||||||||
Runoff segment |
||||||||
Corporate and Other activities |
( |
) | ||||||
Total revenues |
$ | $ | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Add: net income from continuing operations attributable to noncontrolling interests |
||||||||
Add: net income from discontinued operations attributable to noncontrolling interests |
||||||||
Net income |
||||||||
Less: income (loss) from discontinued operations, net of taxes |
( |
) | ||||||
Income from continuing operations |
||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
||||||||
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Net investment (gains) losses, net |
( |
) | ( |
) | ||||
(Gains) losses on early extinguishment of debt |
||||||||
Expenses related to restructuring |
||||||||
Taxes on adjustments |
||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Enact segment |
$ | $ | ||||||
U.S. Life Insurance segment: |
||||||||
Long-term care insurance |
||||||||
Life insurance |
( |
) | ( |
) | ||||
Fixed annuities |
||||||||
U.S. Life Insurance segment |
( |
) | ||||||
Runoff segment |
||||||||
Corporate and Other activities |
( |
) | ( |
) | ||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
(Amounts in millions) |
March 31, 2022 |
December 31, 2021 |
||||||
Assets: |
||||||||
Enact segment |
$ | $ | ||||||
U.S. Life Insurance segment |
||||||||
Runoff segment |
||||||||
Corporate and Other activities |
||||||||
Total assets |
$ | $ | ||||||
(Amounts in millions) |
Net unrealized investment gains (losses) (1) |
Derivatives qualifying as hedges (2) |
Foreign currency translation and other adjustments |
Total |
||||||||||||
Balances as of January 1, 2022 |
$ | $ | $ | ( |
) | $ | ||||||||||
OCI before reclassifications |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Amounts reclassified from (to) OCI |
( |
) | ( |
) | ||||||||||||
Current period OCI |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balances as of March 31, 2022 before noncontrolling interests |
( |
) | ||||||||||||||
Less: change in OCI attributable to noncontrolling interests |
( |
) | ( |
) | ||||||||||||
Balances as of March 31, 2022 |
$ | $ | $ | ( |
) | $ | ||||||||||
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
(Amounts in millions) |
Net unrealized investment gains (losses) (1) |
Derivatives qualifying as hedges (2) |
Foreign currency translation and other adjustments |
Total |
||||||||||||
Balances as of January 1, 2021 |
$ | $ | $ | $ | ||||||||||||
OCI before reclassifications |
( |
) | ( |
) | ( |
) | ||||||||||
Amounts reclassified from (to) OCI |
( |
) | ( |
) | ( |
) | ||||||||||
Current period OCI |
( |
) | ( |
) | ( |
) | ||||||||||
Balances as of March 31, 2021 before noncontrolling interests |
||||||||||||||||
Less: change in OCI attributable to noncontrolling interests |
( |
) | ||||||||||||||
Balances as of March 31, 2021 |
$ | $ | $ | ( |
) | $ | ||||||||||
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
Amount reclassified from accumulated other comprehensive income (loss) |
Affected line item in the consolidated statements of income | |||||||||
Three months ended March 31, |
||||||||||
(Amounts in millions) |
2022 |
2021 |
||||||||
Net unrealized investment (gains) losses: |
||||||||||
Unrealized (gains) losses on investments (1) |
$ | $ | ( |
) | Net investment (gains) losses | |||||
Income taxes |
( |
) | Provision for income taxes | |||||||
Total |
$ | $ | ( |
) | ||||||
Derivatives qualifying as hedges: |
||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | ( |
) | Net investment income | |||
Interest rate swaps hedging assets |
( |
) | Net investment (gains) losses | |||||||
Interest rate swaps hedging liabilities |
Interest expense | |||||||||
Foreign currency swaps |
( |
) | Net investment income | |||||||
Income taxes |
Provision for income taxes | |||||||||
Total |
$ | ( |
) | $ | ( |
) | ||||
(1) |
Amounts exclude adjustments to DAC, present value of future profits, sales inducements and benefit reserves. |
(Amounts in millions) |
Three months ended March 31, 2021 |
|||
Revenues: |
||||
Premiums |
$ | |||
Net investment income |
||||
Net investment gains (losses) |
( |
) | ||
|
|
|||
Total revenues |
||||
|
|
|||
Benefits and expenses: |
||||
Benefits and other changes in policy reserves |
||||
Acquisition and operating expenses, net of deferrals |
||||
Amortization of deferred acquisition costs and intangibles |
||||
Interest expense |
||||
|
|
|||
Total benefits and expenses |
||||
|
|
|||
Income before income taxes and loss on sale (1) |
||||
Provision for income taxes |
||||
|
|
|||
Income before loss on sale |
||||
Loss on sale, net of taxes |
( |
) | ||
|
|
|||
Income from discontinued operations, net of taxes |
||||
|
|
|||
Less: net income from discontinued operations attributable to noncontrolling interests |
||||
|
|
|||
Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
$ | |||
|
|
(1) |
The three months ended March 31, 2021, includes pre-tax income from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $ |
(Amounts in millions) |
British Pounds |
U.S. Dollar |
||||||||||||||
March 31, 2022 |
December 31, 2021 |
March 31, 2022 |
December 31, 2021 |
|||||||||||||
Installment payments due to AXA: |
||||||||||||||||
June 2022: |
||||||||||||||||
Beginning balance |
£ | £ | $ | $ | ||||||||||||
Prepayments (1) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Ending balance |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
September 2022: |
||||||||||||||||
Beginning balance |
||||||||||||||||
Amounts billed as future losses |
||||||||||||||||
Prepayments (1) |
( |
) | ( |
) | ||||||||||||
Foreign exchange and other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Ending balance |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total amounts due under the promissory note |
||||||||||||||||
Future claims: |
||||||||||||||||
Estimated beginning balance |
||||||||||||||||
Plus: Additional amounts invoiced |
||||||||||||||||
Change in estimated future claims |
( |
) | ( |
) | ||||||||||||
Less: Amounts billed and included as mandatory prepayments |
( |
) | ( |
) | ||||||||||||
Less: Amounts paid |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Foreign exchange and other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Estimated future claims |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total amounts due to AXA under the settlement agreement |
£ | £ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
(1) |
On March 3, 2021, we completed the sale of Genworth Australia and received net proceeds of approximately AUD |
• | we may be unable to successfully execute our strategic plans |
• | risks relating to estimates, assumptions and valuations |
reserves and margin reviews, including risks that additional information obtained in the future or other changes to assumptions or methodologies materially affect margins; or other changes to assumptions or methodologies materially affect margins; the inability to accurately estimate the impacts of COVID-19; inaccurate models; the need to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons; accelerated amortization of deferred acquisition costs (“DAC”) and present value of future profits (“PVFP”) (including as a result of any future changes we may make to our assumptions, methodologies or otherwise in connection with periodic or other reviews); adverse impact on our financial results as a result of projected profits followed by projected losses (as is currently the case with our long-term care insurance business); changes in valuation of fixed maturity and equity securities; and the benefits Enact Holdings realizes from its future loss mitigation actions or programs may be limited; |
• | liquidity, financial strength and credit ratings, and counterparty and credit risks |
• | risks relating to economic, market and political conditions |
• | regulatory and legal risks COVID-19; adverse changes in regulatory requirements, including risk-based capital; inability of Enact Holdings to continue to meet the requirements mandated by PMIERs, including as a result of increased delinquencies caused by COVID-19; inability of Enact Holdings’ U.S. mortgage insurance subsidiaries to meet minimum statutory capital requirements; the influence of Federal National Mortgage Association (“Fannie Mae”), Federal Home Loan Mortgage Corporation (“Freddie Mac”) and a small number of large mortgage lenders in the U.S. mortgage insurance market and adverse changes to the role or structure of Fannie Mae and Freddie Mac; adverse changes in regulations affecting Enact Holdings, including any additional restrictions placed on Enact Holdings by government and government-owned enterprises and the GSEs in connection with additional capital transactions; inability to continue to implement actions to mitigate the impact of statutory reserve requirements; changes in accounting and reporting standards, including new accounting guidance (that is effective for us on January 1, 2023) related to long-duration insurance contracts; |
• | operational risks |
competition with government-owned and government-sponsored enterprises may put Enact Holdings at a competitive disadvantage on pricing and other terms and conditions; the design and effectiveness of our disclosure controls and procedures and internal control over financial reporting may not prevent all errors, misstatements or misrepresentations; and failure or any compromise of the security of our computer systems, disaster recovery systems, business continuity plans and failures to safeguard or breaches of confidential information; |
• | insurance and product-related risks |
• | other general risks |
• | Premiums |
• | Net investment income |
• | Net investment gains (losses) |
• | Policy fees and other income |
• | Benefits and other changes in policy reserves |
• | Interest credited |
• | Acquisition and operating expenses, net of deferrals |
• | Amortization of deferred acquisition costs and intangibles |
• | Interest expense |
• | Income taxes |
difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other activities. |
• | Net income from continuing operations attributable to noncontrolling interests |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 931 | $ | 968 | $ | (37 | ) | (4 | )% | |||||||
Net investment income |
764 | 801 | (37 | ) | (5 | )% | ||||||||||
Net investment gains (losses) |
28 | 33 | (5 | ) | (15 | )% | ||||||||||
Policy fees and other income |
169 | 183 | (14 | ) | (8 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
1,892 | 1,985 | (93 | ) | (5 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1,139 | 1,218 | (79 | ) | (6 | )% | ||||||||||
Interest credited |
125 | 131 | (6 | ) | (5 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
271 | 275 | (4 | ) | (1 | )% | ||||||||||
Amortization of deferred acquisition costs and intangibles |
92 | 77 | 15 | 19 | % | |||||||||||
Interest expense |
26 | 51 | (25 | ) | (49 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
1,653 | 1,752 | (99 | ) | (6 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
239 | 233 | 6 | 3 | % | |||||||||||
Provision for income taxes |
58 | 59 | (1 | ) | (2 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
181 | 174 | 7 | 4 | % | |||||||||||
Income (loss) from discontinued operations, net of taxes |
(2 | ) | 21 | (23 | ) | (110 | )% | |||||||||
|
|
|
|
|
|
|||||||||||
Net income |
179 | 195 | (16 | ) | (8 | )% | ||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
30 | — | 30 | NM | (1) | |||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— | 8 | (8 | ) | (100 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 149 | $ | 187 | $ | (38 | ) | (20 | )% | |||||||
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | 151 | $ | 174 | $ | (23 | ) | (13 | )% | |||||||
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
(2 | ) | 13 | (15 | ) | (115 | )% | |||||||||
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 149 | $ | 187 | $ | (38 | ) | (20 | )% | |||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 149 | $ | 187 | ||||
Add: net income from continuing operations attributable to noncontrolling interests |
30 | — | ||||||
Add: net income from discontinued operations attributable to noncontrolling interests |
— | 8 | ||||||
|
|
|
|
|||||
Net income |
179 | 195 | ||||||
Less: income (loss) from discontinued operations, net of taxes |
(2 | ) | 21 | |||||
|
|
|
|
|||||
Income from continuing operations |
181 | 174 | ||||||
Less: net income from continuing operations attributable to noncontrolling interests |
30 | — | ||||||
|
|
|
|
|||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
151 | 174 | ||||||
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Net investment (gains) losses, net |
(28 | ) | (33 | ) | ||||
(Gains) losses on early extinguishment of debt |
3 | 4 | ||||||
Expenses related to restructuring |
— | 21 | ||||||
Taxes on adjustments |
5 | 2 | ||||||
|
|
|
|
|||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 131 | $ | 168 | ||||
|
|
|
|
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions, except per share amounts) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
Basic |
$ | 0.30 | $ | 0.35 | $ | (0.05 | ) | (14 | )% | |||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | 0.29 | $ | 0.34 | $ | (0.05 | ) | (15 | )% | |||||||
|
|
|
|
|
|
|
|
|||||||||
Net income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
Basic |
$ | 0.29 | $ | 0.37 | $ | (0.08 | ) | (22 | )% | |||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | 0.29 | $ | 0.37 | $ | (0.08 | ) | (22 | )% | |||||||
|
|
|
|
|
|
|
|
|||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||
Basic |
$ | 0.26 | $ | 0.33 | $ | (0.07 | ) | (21 | )% | |||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
$ | 0.25 | $ | 0.33 | $ | (0.08 | ) | (24 | )% | |||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average common shares outstanding: |
||||||||||||||||
Basic |
508.3 | 506.0 | ||||||||||||||
|
|
|
|
|||||||||||||
Diluted |
517.4 | 513.8 | ||||||||||||||
|
|
|
|
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Enact segment |
$ | 135 | $ | 126 | $ | 9 | 7 | % | ||||||||
U.S. Life Insurance segment: |
||||||||||||||||
Long-term care insurance |
59 | 95 | (36 | ) | (38 | )% | ||||||||||
Life insurance |
(79 | ) | (63 | ) | (16 | ) | (25 | )% | ||||||||
Fixed annuities |
16 | 30 | (14 | ) | (47 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
U.S. Life Insurance segment |
(4 | ) | 62 | (66 | ) | (106 | )% | |||||||||
|
|
|
|
|
|
|||||||||||
Runoff segment |
9 | 12 | (3 | ) | (25 | )% | ||||||||||
Corporate and Other activities |
(9 | ) | (32 | ) | 23 | 72 | % | |||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 131 | $ | 168 | $ | (37 | ) | (22 | )% | |||||||
|
|
|
|
|
|
• | Net income for the three months ended March 31, 2022 and 2021 was $149 million and $187 million, respectively, and adjusted operating income was $131 million and $168 million, respectively. Our Enact segment drove our first quarter of 2022 consolidated financial results, reporting $135 million of adjusted operating income, an increase of 7% compared to the first quarter of 2021. Our U.S. Life Insurance segment reported an adjusted operating loss of $4 million in the first quarter of 2022 driven mostly by unfavorable life insurance operating results, which reported an adjusted operating loss of $79 million for the three months ended March 31, 2022, an increase of 25% compared to the three months ended March 31, 2021. The following is a summary comparison of adjusted operating income (loss) for our segments and Corporate and Other activities: |
• | Our Enact segment had adjusted operating income of $135 million and $126 million for the three months ended March 31, 2022 and 2021, respectively. |
• | The increase was primarily attributable to lower losses largely from a favorable reserve adjustment of $40 million in the current year primarily related to COVID-19 delinquencies in 2020 curing at levels above original reserve expectations compared to reserve strengthening of $8 million on pre-COVID-19 delinquencies in the prior year, as well as from lower new delinquencies in the current year. |
• | These improvements were partially offset by lower premiums and the minority initial public offering (“IPO”) of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6% and resulted in lower net income of $30 million in the current year. |
• | Our U.S. Life Insurance segment had an adjusted operating loss of $4 million for the three months ended March 31, 2022 compared to adjusted operating income of $62 million for the three months ended March 31, 2021. |
• | Long-term care insurance: |
• | Adjusted operating income decreased $36 million primarily from a decrease in claim terminations driven mostly by lower mortality, higher severity and frequency of new claims, less favorable development on incurred but not reported (“IBNR”) claims, lower renewal premiums and lower net investment income. |
• | These unfavorable developments were partially offset by higher premiums and reduced benefits of $61 million in the current year from in-force rate actions approved and implemented, which included a net favorable impact from policyholder benefit reduction elections made as part of a legal settlement. |
• | To account for the change in experience related to mortality and claim incidence due to COVID-19, we increased claim reserves by $76 million in the prior year. In the first quarter of 2022, as the impacts of COVID-19 lessened, we reduced claim reserves by $30 million. |
• | Life insurance: |
• | The adjusted operating loss increased $16 million mainly attributable to a $20 million legal settlement accrual, partially offset by lower mortality in the current year compared to the prior year. |
• | Fixed annuities: |
• | Adjusted operating income decreased $14 million mainly attributable to lower net spreads and lower mortality in our single premium immediate annuities in the current year. |
• | Our Runoff segment had adjusted operating income of $9 million and $12 million for the three months ended March 31, 2022 and 2021, respectively. |
• | The decrease was predominantly due to unfavorable equity market performance and higher interest rates resulting in a decline in the average account values of our variable annuity products reducing fee income in the current year. |
• | Corporate and Other activities had an adjusted operating loss of $9 million and $32 million for the three months ended March 31, 2022 and 2021, respectively. |
• | The decrease in the loss was primarily related to lower interest expense in the current year. |
• | PMIERs compliance: |
• | Enact’s PMIERs sufficiency ratio was 176% or $2,261 million above the published PMIERs requirements as of March 31, 2022. |
• | As of March 31, 2022, Enact had estimated available assets of $5,222 million against $2,961 million net required assets under PMIERs compared to available assets of $5,077 million against $3,074 million net required assets as of December 31, 2021 (PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE restrictions imposed on Enact Holdings). |
• | The increase in the PMIERs sufficiency was driven primarily by the completion of two excess of loss reinsurance transactions in the first quarter of 2022, which added approximately $370 million of additional PMIERs capital credit as of March 31, 2022, as well as lapses, business cash flows and lower delinquencies, partially offset by new insurance written and amortization of existing reinsurance transactions. |
• | As of March 31, 2022 and December 31, 2021, Enact’s PMIERs required assets benefited by $272 million and $390 million, respectively, from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans. |
• | Dividends: |
• | Enact Holdings’ board of directors approved the initiation of a quarterly dividend commencing with a dividend of $10.14 per share in the second quarter of 2022. |
• | Enact Holdings will continue to evaluate the most appropriate amount of total capital to return to shareholders for the remainder of 2022, which could include a potential special dividend later in 2022 and/or other capital returns to shareholders. |
• | Long-term care insurance multi-year in-force rate action plan: |
• | During the first quarter of 2022, we continued to make strong progress on our long-term care insurance in-force rate action plan. |
• | We estimate that the cumulative economic benefit of our long-term care insurance multi-year in-force rate action plan through the first quarter of 2022 was approximately $20.4 billion, on a net present value basis, of the total expected amount required of $28.7 billion. |
• | We received 38 filing approvals from 15 states during the three months ended March 31, 2022, representing a weighted-average increase of 29% on approximately $354 million in annualized in-force premiums, or approximately $101 million of incremental annual premiums. |
• | We expect to begin submitting new filings in the second quarter of 2022. |
• | Profits followed by losses in our long-term care insurance business: |
• | Future projections in our long-term care insurance block, excluding the acquired block, indicate we have projected profits in earlier periods followed by projected losses in later periods. |
• | As a result of this pattern of projected profits followed by projected losses, we will ratably accrue additional future policy benefit reserves over the profitable periods, currently expected to be through 2031, by the amounts necessary to offset estimated losses during the periods that follow. |
• | As of March 31, 2022 and December 31, 2021, the total amount accrued for profits followed by losses was $1,473 million and $1,274 million, respectively. |
• | Execution of strategic plan to reduce debt maturities: |
• | We continue to focus on deleveraging with a goal of reducing debt at Genworth Holdings, the issuer of our outstanding public debt, to approximately $1.0 billion or less over time. |
• | As of March 31, 2022, Genworth Holdings had outstanding $1.1 billion of long-term debt, with no debt maturities until February 2024. |
• | During the first quarter of 2022, Genworth Holdings repurchased $82 million principal amount of its 4.80% senior notes due in February 2024, leaving a remaining balance outstanding of $200 million as of March 31, 2022. We plan to retire the remaining outstanding balance in the third quarter of 2022, depending upon economic and business conditions, among other considerations. |
• | Repayment of the majority of AXA S.A.’s (“AXA”) future billings: |
• | In connection with the AXA settlement agreement, we agreed to make payments for a significant portion of unprocessed claims to be invoiced by AXA in future periods. |
• | In February 2022, Genworth Holdings paid AXA $30 million, which constitutes the majority of the estimated remaining unprocessed claims. |
• | Genworth Financial share repurchase program: |
• | On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial may repurchase up to $350 million of its outstanding Class A common stock. |
• | EMICO to maintain 120% of PMIERs minimum required assets during 2022 and 125% thereafter; |
• | Enact Holdings to retain $300 million of its holding company cash that can be drawn down exclusively for its debt service or to contribute to EMICO to meet its regulatory capital needs including PMIERs; and |
• | written approval must be received from the GSEs prior to any additional debt issuance by either EMICO or Enact Holdings. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 234 | $ | 252 | $ | (18 | ) | (7 | )% | |||||||
Net investment income |
35 | 35 | — | — | % | |||||||||||
Net investment gains (losses) |
— | (1 | ) | 1 | 100 | % | ||||||||||
Policy fees and other income |
1 | 2 | (1 | ) | (50 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
270 | 288 | (18 | ) | (6 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
(10 | ) | 55 | (65 | ) | (118 | )% | |||||||||
Acquisition and operating expenses, net of deferrals |
54 | 57 | (3 | ) | (5 | )% | ||||||||||
Amortization of deferred acquisition costs and intangibles |
3 | 4 | (1 | ) | (25 | )% | ||||||||||
Interest expense |
13 | 13 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
60 | 129 | (69 | ) | (53 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
210 | 159 | 51 | 32 | % | |||||||||||
Provision for income taxes |
45 | 34 | 11 | 32 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
165 | 125 | 40 | 32 | % | |||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
30 | — | 30 | NM | (1) | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
135 | 125 | 10 | 8 | % | |||||||||||
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Net investment (gains) losses |
— | 1 | (1 | ) | (100 | )% | ||||||||||
Taxes on adjustments |
— | — | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 135 | $ | 126 | $ | 9 | 7 | % | ||||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
As of or for the three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Primary insurance in-force (1) |
$ | 231,853 | $ | 210,187 | $ | 21,666 | 10 | % | ||||||||
Risk in-force: |
||||||||||||||||
Primary |
$ | 58,295 | $ | 52,866 | $ | 5,429 | 10 | % | ||||||||
Pool |
97 | 134 | (37 | ) | (28 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total risk in-force |
$ | 58,392 | $ | 53,000 | $ | 5,392 | 10 | % | ||||||||
|
|
|
|
|
|
|||||||||||
New insurance written |
$ | 18,823 | $ | 24,934 | $ | (6,111 | ) | (25 | )% |
(1) |
Primary insurance in-force represents the aggregate unpaid principal balance for loans Enact insures. Original loan balances are primarily used to determine premiums. |
Three months ended March 31, |
Increase (decrease) |
|||||||||||
2022 |
2021 |
2022 vs. 2021 |
||||||||||
Loss ratio |
(4 | )% | 22 | % | (26 | )% | ||||||
Expense ratio |
24 | % | 24 | % | — | % |
(Amounts in millions) |
2022 |
2021 |
||||||
Primary insurance in-force by loan-to-value ratio at origination: |
||||||||
95.01% and above |
$ | 36,867 | $ | 33,757 | ||||
90.01% to 95.00% |
96,419 | 92,124 | ||||||
85.01% to 90.00% |
66,226 | 58,098 | ||||||
85.00% and below |
32,341 | 26,208 | ||||||
|
|
|
|
|||||
Total |
$ | 231,853 | $ | 210,187 | ||||
|
|
|
|
|||||
Primary risk in-force by loan-to-value ratio at origination: |
||||||||
95.01% and above |
$ | 10,379 | $ | 9,151 | ||||
90.01% to 95.00% |
27,987 | 26,637 | ||||||
85.01% to 90.00% |
16,082 | 13,997 | ||||||
85.00% and below |
3,847 | 3,081 | ||||||
|
|
|
|
|||||
Total |
$ | 58,295 | $ | 52,866 | ||||
|
|
|
|
|||||
Primary insurance in-force by FICO (1) score at origination: |
||||||||
Over 760 |
$ | 93,222 | $ | 79,285 | ||||
740-759 |
36,821 | 33,607 | ||||||
720-739 |
32,363 | 30,295 | ||||||
700-719 |
27,620 | 26,309 | ||||||
680-699 |
21,259 | 20,777 | ||||||
660-679 (2) |
10,805 | 10,001 | ||||||
640-659 |
6,188 | 5,981 | ||||||
620-639 |
2,774 | 2,893 | ||||||
<620 |
801 | 1,039 | ||||||
|
|
|
|
|||||
Total |
$ | 231,853 | $ | 210,187 | ||||
|
|
|
|
|||||
Primary risk in-force by FICO score at origination: |
||||||||
Over 760 |
$ | 23,326 | $ | 19,829 | ||||
740-759 |
9,267 | 8,442 | ||||||
720-739 |
8,224 | 7,715 | ||||||
700-719 |
6,974 | 6,678 | ||||||
680-699 |
5,334 | 5,231 | ||||||
660-679 (2) |
2,715 | 2,484 | ||||||
640-659 |
1,550 | 1,485 | ||||||
620-639 |
699 | 734 | ||||||
<620 |
206 | 268 | ||||||
|
|
|
|
|||||
Total |
$ | 58,295 | $ | 52,866 | ||||
|
|
|
|
(1) |
Fair Isaac Company. |
(2) |
Loans with unknown FICO scores are included in the 660-679 category. |
March 31, 2022 |
December 31, 2021 |
March 31, 2021 |
||||||||||
Primary insurance: |
||||||||||||
Insured loans in-force |
941,689 | 937,350 | 922,186 | |||||||||
Delinquent loans |
22,571 | 24,820 | 41,332 | |||||||||
Percentage of delinquent loans (delinquency rate) |
2.40 | % | 2.65 | % | 4.48 | % |
March 31, 2022 |
||||||||||||||||
(Dollar amounts in millions) |
Delinquencies |
Direct case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
Payments in default: |
||||||||||||||||
3 payments or less |
6,837 | $ | 38 | $ | 359 | 11 | % | |||||||||
4 - 11 payments |
6,875 | 115 | 392 | 29 | % | |||||||||||
12 payments or more |
8,859 | 438 | 515 | 85 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
22,571 | $ | 591 | $ | 1,266 | 47 | % | |||||||||
|
|
|
|
|
|
December 31, 2021 |
||||||||||||||||
(Dollar amounts in millions) |
Delinquencies |
Direct case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
Payments in default: |
||||||||||||||||
3 payments or less |
6,586 | $ | 35 | $ | 340 | 10 | % | |||||||||
4 - 11 payments |
7,360 | 111 | 426 | 26 | % | |||||||||||
12 payments or more |
10,874 | 460 | 643 | 72 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
24,820 | $ | 606 | $ | 1,409 | 43 | % | |||||||||
|
|
|
|
|
|
(1) |
Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
Percent of primary risk in-force as of March 31, 2022 |
Percent of direct case reserves as of March 31, 2022 (1) |
Delinquency rate as of |
||||||||||||||||||
March 31, 2022 |
December 31, 2021 |
March 31, 2021 |
||||||||||||||||||
By State: |
||||||||||||||||||||
California |
11 | % | 11 | % | 2.75 | % | 3.17 | % | 5.76 | % | ||||||||||
Texas |
8 | % | 8 | % | 2.51 | % | 2.89 | % | 5.25 | % | ||||||||||
Florida (2) |
7 | % | 9 | % | 2.51 | % | 2.97 | % | 5.97 | % | ||||||||||
New York (2) |
5 | % | 12 | % | 3.51 | % | 3.80 | % | 6.36 | % | ||||||||||
Illinois (2) |
5 | % | 6 | % | 2.85 | % | 3.09 | % | 5.07 | % | ||||||||||
Michigan |
4 | % | 2 | % | 1.87 | % | 1.87 | % | 2.68 | % | ||||||||||
Arizona |
4 | % | 2 | % | 1.92 | % | 2.31 | % | 4.06 | % | ||||||||||
North Carolina |
3 | % | 2 | % | 1.96 | % | 2.18 | % | 3.60 | % | ||||||||||
Pennsylvania (2) |
3 | % | 3 | % | 2.30 | % | 2.38 | % | 3.83 | % | ||||||||||
Washington |
3 | % | 3 | % | 2.68 | % | 2.98 | % | 5.47 | % |
(1) |
Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
(2) |
Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be complete. |
Percent of primary risk in-force as of March 31, 2022 |
Percent of direct case reserves as of March 31, 2022 (1) |
Delinquency rate as of |
||||||||||||||||||
March 31, 2022 |
December 31, 2021 |
March 31, 2021 |
||||||||||||||||||
By MSA or MD: |
||||||||||||||||||||
Chicago-Naperville, IL MD |
3 | % | 5 | % | 3.39 | % | 3.68 | % | 6.28 | % | ||||||||||
Phoenix, AZ MSA |
3 | % | 2 | % | 1.92 | % | 2.36 | % | 4.12 | % | ||||||||||
New York, NY MD |
3 | % | 8 | % | 4.68 | % | 5.32 | % | 9.56 | % | ||||||||||
Atlanta, GA MSA |
2 | % | 3 | % | 2.92 | % | 3.28 | % | 6.10 | % | ||||||||||
Washington-Arlington, DC MD |
2 | % | 2 | % | 2.50 | % | 2.96 | % | 5.84 | % | ||||||||||
Houston, TX MSA |
2 | % | 3 | % | 3.20 | % | 3.61 | % | 6.89 | % | ||||||||||
Riverside-San Bernardino, CA MSA |
2 | % | 2 | % | 3.05 | % | 3.42 | % | 6.53 | % | ||||||||||
Los Angeles-Long Beach, CA MD |
2 | % | 3 | % | 3.22 | % | 3.95 | % | 7.30 | % | ||||||||||
Dallas, TX MD |
2 | % | 2 | % | 2.04 | % | 2.31 | % | 4.59 | % | ||||||||||
Nassau County, NY MD |
2 | % | 5 | % | 5.02 | % | 5.55 | % | 10.13 | % |
(1) |
Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
(Amounts in millions) |
Percent of direct case reserves (1) |
Primary insurance in-force |
Percent of total |
Primary risk in-force |
Percent of total |
Delinquency rate |
||||||||||||||||||
Policy Year |
||||||||||||||||||||||||
2008 and prior |
25 | % | $ | 7,723 | 3 | % | $ | 1,991 | 3 | % | 10.41 | % | ||||||||||||
2009 to 2014 |
5 | 2,946 | 1 | 788 | 1 | 5.34 | % | |||||||||||||||||
2015 |
5 | 3,960 | 2 | 1,058 | 2 | 4.06 | % | |||||||||||||||||
2016 |
7 | 8,076 | 4 | 2,147 | 4 | 3.48 | % | |||||||||||||||||
2017 |
10 | 8,023 | 4 | 2,094 | 4 | 4.43 | % | |||||||||||||||||
2018 |
12 | 8,306 | 4 | 2,092 | 4 | 5.48 | % | |||||||||||||||||
2019 |
17 | 19,609 | 8 | 4,935 | 8 | 3.44 | % | |||||||||||||||||
2020 |
15 | 65,807 | 28 | 16,606 | 28 | 1.49 | % | |||||||||||||||||
2021 |
4 | 88,757 | 38 | 21,959 | 38 | 0.58 | % | |||||||||||||||||
2022 |
— | 18,646 | 8 | 4,625 | 8 | 0.04 | % | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total portfolio |
100 | % | $ | 231,853 | 100 | % | $ | 58,295 | 100 | % | 2.40 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 695 | $ | 714 | $ | (19 | ) | (3 | )% | |||||||
Net investment income |
676 | 716 | (40 | ) | (6 | )% | ||||||||||
Net investment gains (losses) |
56 | 42 | 14 | 33 | % | |||||||||||
Policy fees and other income |
137 | 148 | (11 | ) | (7 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
1,564 | 1,620 | (56 | ) | (3 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1,141 | 1,155 | (14 | ) | (1 | )% | ||||||||||
Interest credited |
82 | 90 | (8 | ) | (9 | )% | ||||||||||
Acquisition and operating expenses, net of deferrals |
199 | 192 | 7 | 4 | % | |||||||||||
Amortization of deferred acquisition costs and intangibles |
83 | 68 | 15 | 22 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
1,505 | 1,505 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations before income taxes |
59 | 115 | (56 | ) | (49 | )% | ||||||||||
Provision for income taxes |
20 | 32 | (12 | ) | (38 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
39 | 83 | (44 | ) | (53 | )% | ||||||||||
Adjustments to income from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (1) |
(55 | ) | (41 | ) | (14 | ) | (34 | )% | ||||||||
Expenses related to restructuring |
— | 14 | (14 | ) | (100 | )% | ||||||||||
Taxes on adjustments |
12 | 6 | 6 | 100 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | (4 | ) | $ | 62 | $ | (66 | ) | (106 | )% | ||||||
|
|
|
|
|
|
(1) |
For the three months ended March 31, 2022 and 2021, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $1 million in each period. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Long-term care insurance |
$ | 59 | $ | 95 | $ | (36 | ) | (38 | )% | |||||||
Life insurance |
(79 | ) | (63 | ) | (16 | ) | (25 | )% | ||||||||
Fixed annuities |
16 | 30 | (14 | ) | (47 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | (4 | ) | $ | 62 | $ | (66 | ) | (106 | )% | ||||||
|
|
|
|
|
|
• | Adjusted operating income in our long-term care insurance business decreased $36 million primarily from a decrease in claim terminations driven mostly by lower mortality, higher severity and frequency of new claims, less favorable development on IBNR claims, lower renewal premiums and lower net investment income. These decreases were partially offset by higher premiums and reduced benefits of $61 million in the current year from in-force rate actions approved and implemented, which included a net favorable impact from policyholder benefit reduction elections made as part of a legal settlement. To account for the change in experience related to mortality and claim incidence due to COVID-19, we increased claim reserves by $76 million in the prior year. In the first quarter of 2022, as the impacts of COVID-19 lessened, we reduced claim reserves by $30 million. |
• | The adjusted operating loss in our life insurance business increased $16 million mainly attributable to a $20 million legal settlement accrual, partially offset by lower mortality in the current year compared to the prior year. |
• | Adjusted operating income in our fixed annuities business decreased $14 million mainly attributable to lower net spreads and lower mortality in our single premium immediate annuities in the current year. |
• | Our long-term care insurance business decreased $25 million primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $15 million of increased premiums in the current year from in-force rate actions approved and implemented. |
• | Our life insurance business increased $6 million primarily driven by lower ceded premiums, partially offset by the continued runoff of our term and whole life insurance products in the current year. |
• | Our long-term care insurance business decreased $18 million largely from lower income of $28 million in the current year mostly attributable to limited partnerships and bond calls, partially offset by higher income of $12 million related to U.S. Government Treasury Inflation Protected Securities (“TIPS”). |
• | Our life insurance business decreased $4 million principally related to lower yields and lower average invested assets in the current year. |
• | Our fixed annuities business decreased $18 million largely attributable to lower average invested assets due to block runoff and from lower bond calls in the current year. |
• | Our long-term care insurance business decreased $17 million primarily due to a more favorable impact of $84 million from reduced benefits in the current year related to in-force rate actions approved and |
implemented, which included policyholder benefit reduction elections made as part of a legal settlement. To account for the change in experience related to mortality and claim incidence due to COVID-19, we increased claim reserves by $96 million in the prior year. In the first quarter of 2022, as the impacts of COVID-19 lessened, we reduced claim reserves by $38 million. These decreases were partially offset by aging of the in-force block, a decrease in claim terminations driven mostly by lower mortality, higher severity and frequency of new claims, less favorable development on IBNR claims and higher incremental reserves of $25 million recorded in connection with an accrual for profits followed by losses in the current year. |
• | Our life insurance business was flat as ceded reinsurance was offset by lower mortality in the current year. |
• | Our fixed annuities business increased $3 million principally from lower mortality in our single premium immediate annuities and higher reserves in our fixed indexed annuity products driven by unfavorable equity market changes in the current year compared to a favorable equity market in the prior year. |
• | Our long-term care insurance business increased $2 million principally related to higher premium taxes, commissions and other expenses of $21 million associated with our in-force rate action plan, which included expenses related to policyholder benefit reduction elections made as part of a legal settlement in the current year, partially offset by restructuring costs in the prior year that did not recur and lower operating costs in the current year. |
• | Our life insurance business increased $7 million primarily due to a $25 million legal settlement accrual, partially offset by lower reinsurance costs in the current year. |
• | Our long-term care insurance business increased $5 million principally from policy terminations and policies entering paid-up status in the current year. |
• | Our life insurance business increased $9 million primarily driven by mortality experience in our universal life insurance products. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Premiums |
$ | 210 | $ | 195 | $ | 15 | 8 | % | ||||||||
Plus: Benefits and other changes in policy reserves (1) |
236 | 152 | 84 | 55 | % | |||||||||||
Less: Acquisition and operating expenses, net of deferrals (2) |
61 | 40 | 21 | 53 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income before taxes |
385 | 307 | 78 | 25 | % | |||||||||||
Income taxes |
81 | 64 | 17 | 27 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income (3) |
$ | 304 | $ | 243 | $ | 61 | 25 | % | ||||||||
|
|
|
|
|
|
(1) |
Amounts represent benefit reductions elected by policyholders as an alternative to increased premiums. These amounts reduced benefits and other changes in policy reserves in our long-term care insurance business for the periods indicated. |
(2) |
Amounts include premium taxes, commissions and other expenses associated with our long-term care insurance in-force rate action plan, which included expenses of $43 million (consisting entirely of cash damages) and $23 million related to policyholder benefit reduction elections made as part of a legal settlement for the three months ended March 31, 2022 and 2021, respectively. Included in the $23 million of expenses for the three months ended March 31, 2021 was $20 million of cash damages. |
(3) |
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders attributable to in-force rate actions excludes reserve updates resulting from profits followed by losses. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Net earned premiums: |
||||||||||||||||
Individual long-term care insurance (1) |
$ | 590 | $ | 615 | $ | (25 | ) | (4 | )% | |||||||
Group long-term care insurance |
31 | 31 | — | — | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | 621 | $ | 646 | $ | (25 | ) | (4 | )% | |||||||
|
|
|
|
|
|
|||||||||||
Loss ratio |
64 | % | 62 | % | 2 | % |
(1) |
For the three months ended March 31, 2022 and 2021, amounts include increased premiums of $210 million and $195 million, respectively, from in-force rate actions approved and implemented. |
As of or for the three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Term and whole life insurance |
||||||||||||||||
Net earned premiums |
$ | 74 | $ | 68 | $ | 6 | 9 | % | ||||||||
Life insurance in-force, net of reinsurance |
49,637 | 77,430 | (27,793 | ) | (36 | )% | ||||||||||
Life insurance in-force before reinsurance |
325,055 | 355,424 | (30,369 | ) | (9 | )% | ||||||||||
Term universal life insurance |
||||||||||||||||
Net deposits |
$ | 49 | $ | 53 | $ | (4 | ) | (8 | )% | |||||||
Life insurance in-force, net of reinsurance |
97,750 | 105,360 | (7,610 | ) | (7 | )% | ||||||||||
Life insurance in-force before reinsurance |
98,392 | 106,055 | (7,663 | ) | (7 | )% | ||||||||||
Universal life insurance |
||||||||||||||||
Net deposits |
$ | 67 | $ | 69 | $ | (2 | ) | (3 | )% | |||||||
Life insurance in-force, net of reinsurance |
30,732 | 32,132 | (1,400 | ) | (4 | )% | ||||||||||
Life insurance in-force before reinsurance |
34,756 | 36,435 | (1,679 | ) | (5 | )% | ||||||||||
Total life insurance |
||||||||||||||||
Net earned premiums and deposits |
$ | 190 | $ | 190 | $ | — | — | % | ||||||||
Life insurance in-force, net of reinsurance |
178,119 | 214,922 | (36,803 | ) | (17 | )% | ||||||||||
Life insurance in-force before reinsurance |
458,203 | 497,914 | (39,711 | ) | (8 | )% |
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Account value, beginning of period |
$ | 10,163 | $ | 11,815 | ||||
Deposits |
18 | 17 | ||||||
Surrenders, benefits and product charges |
(414 | ) | (544 | ) | ||||
|
|
|
|
|||||
Net flows |
(396 | ) | (527 | ) | ||||
Interest credited and investment performance |
61 | 85 | ||||||
Effect of accumulated net unrealized investment gains (losses) |
(323 | ) | (201 | ) | ||||
|
|
|
|
|||||
Account value, end of period |
$ | 9,505 | $ | 11,172 | ||||
|
|
|
|
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Revenues: |
||||||||||||||||
Net investment income |
$ | 50 | $ | 49 | $ | 1 | 2 | % | ||||||||
Net investment gains (losses) |
(15 | ) | (6 | ) | (9 | ) | (150 | )% | ||||||||
Policy fees and other income |
31 | 33 | (2 | ) | (6 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
66 | 76 | (10 | ) | (13 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
8 | 8 | — | — | % | |||||||||||
Interest credited |
43 | 41 | 2 | 5 | % | |||||||||||
Acquisition and operating expenses, net of deferrals |
12 | 13 | (1 | ) | (8 | )% | ||||||||||
Amortization of deferred acquisition costs and intangibles |
6 | 5 | 1 | 20 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
69 | 67 | 2 | 3 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes |
(3 | ) | 9 | (12 | ) | (133 | )% | |||||||||
Provision (benefit) for income taxes |
(1 | ) | 1 | (2 | ) | (200 | )% | |||||||||
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations |
(2 | ) | 8 | (10 | ) | (125 | )% | |||||||||
Adjustments to income (loss) from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (1) |
14 | 5 | 9 | 180 | % | |||||||||||
Taxes on adjustments |
(3 | ) | (1 | ) | (2 | ) | (200 | )% | ||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 9 | $ | 12 | $ | (3 | ) | (25 | )% | |||||||
|
|
|
|
|
|
(1) |
For the three months ended March 31, 2022 and 2021, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million, for each period. |
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Account value, beginning of period |
$ | 4,839 | $ | 5,001 | ||||
Deposits |
5 | 6 | ||||||
Surrenders, benefits and product charges |
(131 | ) | (187 | ) | ||||
|
|
|
|
|||||
Net flows |
(126 | ) | (181 | ) | ||||
Interest credited and investment performance |
(254 | ) | 43 | |||||
|
|
|
|
|||||
Account value, end of period |
$ | 4,459 | $ | 4,863 | ||||
|
|
|
|
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2022 |
2021 |
2022 vs. 2021 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 2 | $ | 2 | $ | — | — | % | ||||||||
Net investment income |
3 | 1 | 2 | 200 | % | |||||||||||
Net investment gains (losses) |
(13 | ) | (2 | ) | (11 | ) | NM | (1) | ||||||||
|
|
|
|
|
|
|||||||||||
Total revenues |
(8 | ) | 1 | (9 | ) | NM | (1) | |||||||||
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
— | — | — | — | % | |||||||||||
Acquisition and operating expenses, net of deferrals |
6 | 13 | (7 | ) | (54 | )% | ||||||||||
Interest expense |
13 | 38 | (25 | ) | (66 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
19 | 51 | (32 | ) | (63 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Loss from continuing operations before income taxes |
(27 | ) | (50 | ) | 23 | 46 | % | |||||||||
Benefit for income taxes |
(6 | ) | (8 | ) | 2 | 25 | % | |||||||||
|
|
|
|
|
|
|||||||||||
Loss from continuing operations |
(21 | ) | (42 | ) | 21 | 50 | % | |||||||||
Adjustments to loss from continuing operations: |
||||||||||||||||
Net investment (gains) losses |
13 | 2 | 11 | NM | (1) | |||||||||||
(Gains) losses on early extinguishment of debt |
3 | 4 | (1 | ) | (25 | )% | ||||||||||
Expenses related to restructuring |
— | 7 | (7 | ) | (100 | )% | ||||||||||
Taxes on adjustments |
(4 | ) | (3 | ) | (1 | ) | (33 | )% | ||||||||
|
|
|
|
|
|
|||||||||||
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders |
$ | (9 | ) | $ | (32 | ) | $ | 23 | 72 | % | ||||||
|
|
|
|
|
|
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
Three months ended March 31, |
Increase (decrease) |
|||||||||||||||||||||||
2022 |
2021 |
2022 vs. 2021 |
||||||||||||||||||||||
(Amounts in millions) |
Yield |
Amount |
Yield |
Amount |
Yield |
Amount |
||||||||||||||||||
Fixed maturity securities—taxable |
4.4 | % | $ | 580 | 4.5 | % | $ | 599 | (0.1 | )% | $ | (19 | ) | |||||||||||
Fixed maturity securities—non-taxable |
3.6 | % | 1 | 6.3 | % | 2 | (2.7 | )% | (1 | ) | ||||||||||||||
Equity securities |
3.7 | % | 2 | 3.8 | % | 3 | (0.1 | )% | (1 | ) | ||||||||||||||
Commercial mortgage loans |
4.7 | % | 81 | 4.6 | % | 78 | 0.1 | % | 3 | |||||||||||||||
Policy loans |
9.8 | % | 50 | 10.1 | % | 50 | (0.3 | )% | — | |||||||||||||||
Limited partnerships (1) |
1.4 | % | 7 | 11.2 | % | 31 | (9.8 | )% | (24 | ) | ||||||||||||||
Other invested assets (2) |
64.8 | % | 63 | 65.0 | % | 58 | (0.2 | )% | 5 | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Gross investment income before expenses and fees |
4.8 | % | 784 | 5.0 | % | 821 | (0.2 | )% | (37 | ) | ||||||||||||||
Expenses and fees |
(0.1 | )% | (20 | ) | (0.2 | )% | (20 | ) | 0.1 | % | — | |||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Net investment income |
4.7 | % | $ | 764 | 4.8 | % | $ | 801 | (0.1 | )% | $ | (37 | ) | |||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Average invested assets and cash |
$ | 65,395 | $ | 66,233 | $ | (838 | ) | |||||||||||||||||
|
|
|
|
|
|
(1) |
Limited partnership investments are primarily equity-based and do not have fixed returns by period. |
(2) |
Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation. |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2022 |
2021 |
||||||
Realized investment gains (losses): |
||||||||
Available-for-sale fixed maturity securities: |
||||||||
Realized gains |
$ | 10 | $ | 7 | ||||
Realized losses |
(18 | ) | (3 | ) | ||||
|
|
|
|
|||||
Net realized gains (losses) on available-for-sale fixed maturity securities |
(8 | ) | 4 | |||||
Net realized gains (losses) on equity securities sold |
— | (5 | ) | |||||
Net realized gains (losses) on limited partnerships |
— | 3 | ||||||
|
|
|
|
|||||
Total net realized investment gains (losses) |
(8 | ) | 2 | |||||
|
|
|
|
|||||
Net change in allowance for credit losses on available-for-sale fixed maturity securities |
— | (2 | ) | |||||
Write-down of available-for-sale fixed maturity securities |
(2 | ) | (1 | ) | ||||
Net unrealized gains (losses) on equity securities still held |
(6 | ) | (8 | ) | ||||
Net unrealized gains (losses) on limited partnerships |
35 | 34 | ||||||
Commercial mortgage loans |
1 | (1 | ) | |||||
Derivative instruments |
4 | 8 | ||||||
Other |
4 | 1 | ||||||
|
|
|
|
|||||
Net investment gains (losses) |
$ | 28 | $ | 33 | ||||
|
|
|
|
• | We recorded net losses of $8 million related to the sale of available-for-sale fixed maturity securities during the three months ended March 31, 2022 compared to $4 million of net gains during the three months ended March 31, 2021. Included in the $8 million of net losses for the three months ended March 31, 2022 was $18 million of realized losses principally related to U.S. corporate securities sold to optimize cash at Genworth Holdings. We also recorded $5 million of net losses related to the sale of equity securities during the three months ended March 31, 2021. |
• | We had $4 million of lower net gains related to derivatives during the three months ended March 31, 2022 compared to the three months ended March 31, 2021 primarily from higher net losses from hedging programs that support our runoff variable annuity products, partially offset by gains on derivative contracts used to protect statutory surplus from equity market fluctuations in the current year compared to losses in the prior year. |
March 31, 2022 |
December 31, 2021 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Available-for-sale fixed maturity securities: |
||||||||||||||||
Public |
$ | 38,219 | 56 | % | $ | 42,501 | 58 | % | ||||||||
Private |
16,808 | 25 | 17,979 | 24 | ||||||||||||
Equity securities |
230 | — | 198 | — | ||||||||||||
Commercial mortgage loans, net |
6,913 | 10 | 6,830 | 9 | ||||||||||||
Policy loans |
2,028 | 3 | 2,050 | 3 | ||||||||||||
Limited partnerships |
2,007 | 3 | 1,900 | 3 | ||||||||||||
Other invested assets |
671 | 1 | 820 | 1 | ||||||||||||
Cash, cash equivalents and restricted cash |
1,291 | 2 | 1,571 | 2 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, restricted cash and invested assets |
$ | 68,167 | 100 | % | $ | 73,849 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | 3,356 | $ | 744 | $ | (3 | ) | $ | — | $ | 4,097 | |||||||||
State and political subdivisions |
3,009 | 206 | (81 | ) | — | 3,134 | ||||||||||||||
Non-U.S. government |
778 | 48 | (42 | ) | — | 784 | ||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
4,345 | 355 | (66 | ) | — | 4,634 | ||||||||||||||
Energy |
2,572 | 175 | (48 | ) | — | 2,699 | ||||||||||||||
Finance and insurance |
8,026 | 406 | (203 | ) | — | 8,229 | ||||||||||||||
Consumer—non-cyclical |
5,070 | 488 | (70 | ) | — | 5,488 | ||||||||||||||
Technology and communications |
3,371 | 213 | (87 | ) | — | 3,497 | ||||||||||||||
Industrial |
1,301 | 73 | (26 | ) | — | 1,348 | ||||||||||||||
Capital goods |
2,346 | 205 | (39 | ) | — | 2,512 | ||||||||||||||
Consumer—cyclical |
1,725 | 86 | (44 | ) | — | 1,767 | ||||||||||||||
Transportation |
1,133 | 124 | (9 | ) | — | 1,248 | ||||||||||||||
Other |
381 | 24 | (4 | ) | — | 401 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
30,270 | 2,149 | (596 | ) | — | 31,823 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
874 | 19 | (15 | ) | — | 878 | ||||||||||||||
Energy |
1,158 | 102 | (19 | ) | — | 1,241 | ||||||||||||||
Finance and insurance |
2,129 | 132 | (70 | ) | — | 2,191 | ||||||||||||||
Consumer—non-cyclical |
665 | 28 | (22 | ) | — | 671 | ||||||||||||||
Technology and communications |
1,055 | 61 | (17 | ) | — | 1,099 | ||||||||||||||
Industrial |
918 | 56 | (21 | ) | — | 953 | ||||||||||||||
Capital goods |
610 | 25 | (16 | ) | — | 619 | ||||||||||||||
Consumer—cyclical |
316 | 5 | (9 | ) | — | 312 | ||||||||||||||
Transportation |
392 | 38 | (7 | ) | — | 423 | ||||||||||||||
Other |
996 | 86 | (16 | ) | — | 1,066 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
9,113 | 552 | (212 | ) | — | 9,453 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed |
1,277 | 57 | (14 | ) | — | 1,320 | ||||||||||||||
Commercial mortgage-backed |
2,369 | 36 | (44 | ) | — | 2,361 | ||||||||||||||
Other asset-backed |
2,108 | 7 | (60 | ) | — | 2,055 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total available-for-sale fixed maturity securities |
$ | 52,280 | $ | 3,799 | $ | (1,052 | ) | $ | — | $ | 55,027 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | 3,368 | $ | 1,184 | $ | — | $ | — | $ | 4,552 | ||||||||||
State and political subdivisions |
2,982 | 474 | (6 | ) | — | 3,450 | ||||||||||||||
Non-U.S. government |
762 | 86 | (13 | ) | — | 835 | ||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
4,330 | 783 | (9 | ) | — | 5,104 | ||||||||||||||
Energy |
2,581 | 363 | (10 | ) | — | 2,934 | ||||||||||||||
Finance and insurance |
8,003 | 1,012 | (24 | ) | — | 8,991 | ||||||||||||||
Consumer—non-cyclical |
5,138 | 1,029 | (8 | ) | — | 6,159 | ||||||||||||||
Technology and communications |
3,345 | 476 | (13 | ) | — | 3,808 | ||||||||||||||
Industrial |
1,322 | 175 | (3 | ) | — | 1,494 | ||||||||||||||
Capital goods |
2,334 | 415 | (4 | ) | — | 2,745 | ||||||||||||||
Consumer—cyclical |
1,703 | 203 | (7 | ) | — | 1,899 | ||||||||||||||
Transportation |
1,122 | 249 | — | — | 1,371 | |||||||||||||||
Other |
379 | 41 | (1 | ) | — | 419 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total U.S. corporate |
30,257 | 4,746 | (79 | ) | — | 34,924 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
867 | 63 | (2 | ) | — | 928 | ||||||||||||||
Energy |
1,194 | 190 | (1 | ) | — | 1,383 | ||||||||||||||
Finance and insurance |
2,171 | 270 | (9 | ) | — | 2,432 | ||||||||||||||
Consumer—non-cyclical |
664 | 81 | (2 | ) | — | 743 | ||||||||||||||
Technology and communications |
1,085 | 166 | (1 | ) | — | 1,250 | ||||||||||||||
Industrial |
933 | 117 | (3 | ) | — | 1,047 | ||||||||||||||
Capital goods |
640 | 66 | (1 | ) | — | 705 | ||||||||||||||
Consumer—cyclical |
316 | 27 | (2 | ) | — | 341 | ||||||||||||||
Transportation |
422 | 68 | (1 | ) | — | 489 | ||||||||||||||
Other |
1,052 | 169 | (4 | ) | — | 1,217 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total non-U.S. corporate |
9,344 | 1,217 | (26 | ) | — | 10,535 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Residential mortgage-backed |
1,325 | 116 | (1 | ) | — | 1,440 | ||||||||||||||
Commercial mortgage-backed |
2,435 | 152 | (3 | ) | — | 2,584 | ||||||||||||||
Other asset-backed |
2,138 | 29 | (7 | ) | — | 2,160 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total available-for-sale fixed maturity securities |
$ | 52,611 | $ | 8,004 | $ | (135 | ) | $ | — | $ | 60,480 | |||||||||
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
December 31, 2021 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Derivatives |
$ | 197 | 29 | % | $ | 414 | 50 | % | ||||||||
Bank loan investments |
381 | 57 | 363 | 45 | ||||||||||||
Short-term investments |
76 | 11 | 26 | 3 | ||||||||||||
Other investments |
17 | 3 | 17 | 2 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other invested assets |
$ | 671 | 100 | % | $ | 820 | 100 | % | ||||||||
|
|
|
|
|
|
|
|
(Notional in millions) |
Measurement |
December 31, 2021 |
Additions |
Maturities/ terminations |
March 31, 2022 |
|||||||||||||||
Derivatives designated as hedges |
|
|||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Notional | $ | 7,653 | $ | — | $ | (58 | ) | $ | 7,595 | ||||||||||
Foreign currency swaps |
Notional | 127 | — | — | 127 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total cash flow hedges |
7,780 | — | (58 | ) | 7,722 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives designated as hedges |
7,780 | — | (58 | ) | 7,722 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Equity index options |
Notional | 1,446 | 300 | (368 | ) | 1,378 | ||||||||||||||
Financial futures |
Notional | 946 | 994 | (1,042 | ) | 898 | ||||||||||||||
Other foreign currency contracts |
Notional | 83 | — | (59 | ) | 24 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives not designated as hedges |
2,475 | 1,294 | (1,469 | ) | 2,300 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total derivatives |
$ | 10,255 | $ | 1,294 | $ | (1,527 | ) | $ | 10,022 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
(Number of policies) |
Measurement |
December 31, 2021 |
Additions |
Maturities/ terminations |
March 31, 2022 |
|||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
GMWB embedded derivatives |
Policies | 21,804 | — | (477 | ) | 21,327 | ||||||||||||||
Fixed index annuity embedded derivatives |
Policies | 9,344 | — | (568 | ) | 8,776 | ||||||||||||||
Indexed universal life embedded derivatives |
Policies | 806 | — | (7 | ) | 799 |
• | Cash, cash equivalents, restricted cash and invested assets decreased $5,682 million primarily from decreases of $5,453 million, $280 million and $149 million in fixed maturity securities, cash, cash equivalents, restricted cash and other invested assets, respectively. The decrease in fixed maturity securities was predominantly related to a decrease in unrealized gains due to an increase in interest rates and from net sales and maturities in the current year. The decrease in cash, cash equivalents and restricted cash was largely related to net withdrawals from our investment contracts, the repurchase of Genworth Holdings’ February 2024 senior notes and a payment to AXA associated with unprocessed claims. These decreases to cash were partially offset by net sales and maturities of investment securities in the current year. The decrease in other invested assets was predominantly driven by lower derivative valuations due to an increase in interest rates in the current year. |
• | DAC increased $164 million principally attributable to shadow accounting adjustments associated with a decrease in unrealized gains in the current year. The shadow accounting adjustments increased DAC by approximately $237 million, mostly in our long-term care insurance business, with an offsetting amount recorded in other comprehensive income (loss). This increase was partially offset by a DAC impairment of $24 million in our term universal life insurance product recorded in connection with our periodic reviews of DAC for recoverability. |
• | Deferred tax asset increased $302 million largely due to a decrease in unrealized gains on derivatives and investments, partially offset by the utilization of net operating losses in the current year. |
• | Separate account assets (and liabilities) decreased $536 million primarily due to unfavorable equity market performance and surrenders in the current year. |
• | Future policy benefits decreased $2,631 million primarily driven by shadow accounting adjustments associated with a decrease in unrealized gains in the current year. The shadow accounting adjustments decreased future policy benefits by approximately $2,707 million, mostly in our long-term care insurance business, with an offsetting amount recorded in other comprehensive income (loss). The decrease was also attributable to reduced benefits of $238 million in the current year related to in-force actions approved and implemented, which included policyholder benefit reduction elections made as part of a legal settlement in our long-term care insurance business. These decreases were partially offset by aging of our long-term care insurance in-force block and higher incremental reserves of $199 million recorded in connection with an accrual for profits followed by losses in the current year. |
• | Policyholder account balances decreased $1,157 million largely driven by shadow accounting adjustments associated with a decrease in unrealized gains in the current year. The shadow accounting adjustments decreased policyholder account balances by approximately $820 million, mostly in our universal life insurance products, with an offsetting amount recorded in other comprehensive income (loss). The decrease was also attributable to surrenders and benefits in our deferred annuity products in the current year. |
• | Other liabilities decreased $95 million principally from lower derivative counterparty collateral held by us, which represents our obligation to return the collateral to the counterparty, due to a decline in derivative valuations driven by a rise in interest rates and due to lower employee payroll accruals. |
These decreases were partially offset by an increase in due to broker largely driven by higher trade volumes at the end of the first quarter of 2022, an increase in derivative liabilities due to rising interest rates and higher legal settlement accruals in the current year. |
• | Long-term borrowings decreased $80 million mostly attributable to the repurchase of Genworth Holdings’ February 2024 senior notes. |
• | We reported net income available to Genworth Financial, Inc.’s common stockholders of $149 million for the three months ended March 31, 2022. |
• | Unrealized gains on investments and derivatives qualifying as hedges decreased $1,010 million and $236 million, respectively, primarily from an increase in interest rates in the current year. |
(Amounts in millions) |
2022 |
2021 |
||||||
Net cash used by operating activities |
$ | (92 | ) | $ | (247 | ) | ||
Net cash from investing activities |
138 | 335 | ||||||
Net cash used by financing activities |
(326 | ) | (780 | ) | ||||
|
|
|
|
|||||
Net decrease in cash before foreign exchange effect |
$ | (280 | ) | $ | (692 | ) | ||
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, at fair value (amortized cost of $52,280 and allowance for credit losses of $—) |
$ | — | $ | — | $ | 55,027 | $ | — | $ | 55,027 | ||||||||||
Equity securities, at fair value |
— | — | 230 | — | 230 | |||||||||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4) |
— | — | 6,938 | — | 6,938 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (25 | ) | — | (25 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commercial mortgage loans, net |
— | — | 6,913 | — | 6,913 | |||||||||||||||
Policy loans |
— | — | 2,028 | — | 2,028 | |||||||||||||||
Limited partnerships |
— | — | 2,007 | — | 2,007 | |||||||||||||||
Other invested assets |
— | 75 | 596 | — | 671 | |||||||||||||||
Investments in subsidiaries |
14,419 | 14,621 | — | (29,040 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total investments |
14,419 | 14,696 | 66,801 | (29,040 | ) | 66,876 | ||||||||||||||
Cash, cash equivalents and restricted cash |
— | 140 | 1,151 | — | 1,291 | |||||||||||||||
Accrued investment income |
— | — | 696 | — | 696 | |||||||||||||||
Deferred acquisition costs |
— | — | 1,310 | — | 1,310 | |||||||||||||||
Intangible assets |
— | — | 159 | — | 159 | |||||||||||||||
Reinsurance recoverable |
— | — | 16,821 | — | 16,821 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (57 | ) | — | (57 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance recoverable, net |
— | — | 16,764 | — | 16,764 | |||||||||||||||
Other assets |
1 | 147 | 292 | — | 440 | |||||||||||||||
Intercompany notes receivable |
16 | 71 | 1 | (88 | ) | — | ||||||||||||||
Deferred tax assets |
1 | 514 | (94 | ) | — | 421 | ||||||||||||||
Separate account assets |
— | — | 5,530 | — | 5,530 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 14,437 | $ | 15,568 | $ | 92,610 | $ | (29,128 | ) | $ | 93,487 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities and equity |
||||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Future policy benefits |
$ | — | $ | — | $ | 38,897 | $ | — | $ | 38,897 | ||||||||||
Policyholder account balances |
— | — | 18,197 | — | 18,197 | |||||||||||||||
Liability for policy and contract claims |
— | — | 11,833 | — | 11,833 | |||||||||||||||
Unearned premiums |
— | — | 639 | — | 639 | |||||||||||||||
Other liabilities |
30 | 64 | 1,322 | — | 1,416 | |||||||||||||||
Intercompany notes payable |
— | 17 | 71 | (88 | ) | — | ||||||||||||||
Long-term borrowings |
— | 1,078 | 741 | — | 1,819 | |||||||||||||||
Separate account liabilities |
— | — | 5,530 | — | 5,530 | |||||||||||||||
Liabilities related to discontinued operations |
— | 1 | 3 | — | 4 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
30 | 1,160 | 77,233 | (88 | ) | 78,335 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity: |
||||||||||||||||||||
Common stock |
1 | — | 4 | (4 | ) | 1 | ||||||||||||||
Additional paid-in capital |
11,857 | 12,726 | 18,142 | (30,868 | ) | 11,857 | ||||||||||||||
Accumulated other comprehensive income (loss) |
2,610 | 2,610 | 2,654 | (5,264 | ) | 2,610 | ||||||||||||||
Retained earnings |
2,639 | (928 | ) | (6,468 | ) | 7,396 | 2,639 | |||||||||||||
Treasury stock, at cost |
(2,700 | ) | — | — | — | (2,700 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
14,407 | 14,408 | 14,332 | (28,740 | ) | 14,407 | ||||||||||||||
Noncontrolling interests |
— | — | 1,045 | (300 | ) | 745 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity |
14,407 | 14,408 | 15,377 | (29,040 | ) | 15,152 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 14,437 | $ | 15,568 | $ | 92,610 | $ | (29,128 | ) | $ | 93,487 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, at fair value (amortized cost of $52,611 and allowance for credit losses of $—) |
$ | — | $ | — | $ | 60,480 | $ | — | $ | 60,480 | ||||||||||
Equity securities, at fair value |
— | — | 198 | — | 198 | |||||||||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4) |
— | — | 6,856 | — | 6,856 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (26 | ) | — | (26 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commercial mortgage loans, net |
— | — | 6,830 | — | 6,830 | |||||||||||||||
Policy loans |
— | — | 2,050 | — | 2,050 | |||||||||||||||
Limited partnerships |
— | — | 1,900 | — | 1,900 | |||||||||||||||
Other invested assets |
— | 27 | 793 | — | 820 | |||||||||||||||
Investments in subsidiaries |
15,517 | 15,626 | — | (31,143 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total investments |
15,517 | 15,653 | 72,251 | (31,143 | ) | 72,278 | ||||||||||||||
Cash, cash equivalents and restricted cash |
— | 331 | 1,240 | — | 1,571 | |||||||||||||||
Accrued investment income |
— | — | 647 | — | 647 | |||||||||||||||
Deferred acquisition costs |
— | — | 1,146 | — | 1,146 | |||||||||||||||
Intangible assets |
— | — | 143 | — | 143 | |||||||||||||||
Reinsurance recoverable |
— | — | 16,868 | — | 16,868 | |||||||||||||||
Less: Allowance for credit losses |
— | — | (55 | ) | — | (55 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Reinsurance recoverable, net |
— | — | 16,813 | — | 16,813 | |||||||||||||||
Other assets |
5 | 207 | 176 | — | 388 | |||||||||||||||
Intercompany notes receivable |
— | 15 | 1 | (16 | ) | — | ||||||||||||||
Deferred tax assets |
4 | 555 | (440 | ) | — | 119 | ||||||||||||||
Separate account assets |
— | — | 6,066 | — | 6,066 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets |
$ | 15,526 | $ | 16,761 | $ | 98,043 | $ | (31,159 | ) | $ | 99,171 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities and equity |
||||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Future policy benefits |
$ | — | $ | — | $ | 41,528 | $ | — | $ | 41,528 | ||||||||||
Policyholder account balances |
— | — | 19,354 | — | 19,354 | |||||||||||||||
Liability for policy and contract claims |
— | — | 11,841 | — | 11,841 | |||||||||||||||
Unearned premiums |
— | — | 672 | — | 672 | |||||||||||||||
Other liabilities |
4 | 64 | 1,443 | — | 1,511 | |||||||||||||||
Intercompany notes payable |
12 | 1 | 3 | (16 | ) | — | ||||||||||||||
Long-term borrowings |
— | 1,159 | 740 | — | 1,899 | |||||||||||||||
Separate account liabilities |
— | — | 6,066 | — | 6,066 | |||||||||||||||
Liabilities related to discontinued operations |
— | 30 | 4 | — | 34 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
16 | 1,254 | 81,651 | (16 | ) | 82,905 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Equity: |
||||||||||||||||||||
Common stock |
1 | — | 4 | (4 | ) | 1 | ||||||||||||||
Additional paid-in capital |
11,858 | 12,724 | 18,135 | (30,859 | ) | 11,858 | ||||||||||||||
Accumulated other comprehensive income (loss) |
3,861 | 3,861 | 3,906 | (7,767 | ) | 3,861 | ||||||||||||||
Retained earnings |
2,490 | (1,078 | ) | (6,709 | ) | 7,787 | 2,490 | |||||||||||||
Treasury stock, at cost |
(2,700 | ) | — | — | — | (2,700 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
15,510 | 15,507 | 15,336 | (30,843 | ) | 15,510 | ||||||||||||||
Noncontrolling interests |
— | — | 1,056 | (300 | ) | 756 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total equity |
15,510 | 15,507 | 16,392 | (31,143 | ) | 16,266 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities and equity |
$ | 15,526 | $ | 16,761 | $ | 98,043 | $ | (31,159 | ) | $ | 99,171 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Revenues: |
||||||||||||||||||||
Premiums |
$ | — | $ | — | $ | 931 | $ | — | $ | 931 | ||||||||||
Net investment income |
(1 | ) | — | 765 | — | 764 | ||||||||||||||
Net investment gains (losses) |
— | — | 28 | — | 28 | |||||||||||||||
Policy fees and other income |
— | — | 169 | — | 169 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
(1 | ) | — | 1,893 | — | 1,892 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||||||
Benefits and other changes in policy reserves |
— | — | 1,139 | — | 1,139 | |||||||||||||||
Interest credited |
— | — | 125 | — | 125 | |||||||||||||||
Acquisition and operating expenses, net of deferrals |
8 | 3 | 260 | — | 271 | |||||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 92 | — | 92 | |||||||||||||||
Interest expense |
— | 13 | 13 | — | 26 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
8 | 16 | 1,629 | — | 1,653 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries |
(9 | ) | (16 | ) | 264 | — | 239 | |||||||||||||
Provision (benefit) for income taxes |
(2 | ) | (3 | ) | 63 | — | 58 | |||||||||||||
Equity in income of subsidiaries |
156 | 172 | — | (328 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
149 | 159 | 201 | (328 | ) | 181 | ||||||||||||||
Loss from discontinued operations, net of taxes |
— | (2 | ) | — | — | (2 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
149 | 157 | 201 | (328 | ) | 179 | ||||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
— | — | 30 | — | 30 | |||||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 149 | $ | 157 | $ | 171 | $ | (328 | ) | $ | 149 | |||||||||
|
|
|
|
|
|
|
|
|
|
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Revenues: |
||||||||||||||||||||
Premiums |
$ | — | $ | — | $ | 3,435 | $ | — | $ | 3,435 | ||||||||||
Net investment income |
(3 | ) | — | 3,373 | — | 3,370 | ||||||||||||||
Net investment gains (losses) |
— | — | 323 | — | 323 | |||||||||||||||
Policy fees and other income |
— | (1 | ) | 703 | 2 | 704 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revenues |
(3 | ) | (1 | ) | 7,834 | 2 | 7,832 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Benefits and expenses: |
||||||||||||||||||||
Benefits and other changes in policy reserves |
— | — | 4,383 | — | 4,383 | |||||||||||||||
Interest credited |
— | — | 508 | — | 508 | |||||||||||||||
Acquisition and operating expenses, net of deferrals |
25 | 44 | 1,154 | — | 1,223 | |||||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 377 | — | 377 | |||||||||||||||
Interest expense |
(1 | ) | 109 | 50 | 2 | 160 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total benefits and expenses |
24 | 153 | 6,472 | 2 | 6,651 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries |
(27 | ) | (154 | ) | 1,362 | — | 1,181 | |||||||||||||
Provision (benefit) for income taxes |
(1 | ) | (33 | ) | 297 | — | 263 | |||||||||||||
Equity in income of subsidiaries |
930 | 1,041 | — | (1,971 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income from continuing operations |
904 | 920 | 1,065 | (1,971 | ) | 918 | ||||||||||||||
Income from discontinued operations, net of taxes |
— | 13 | 14 | — | 27 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
904 | 933 | 1,079 | (1,971 | ) | 945 | ||||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
— | — | 33 | — | 33 | |||||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— | — | 8 | — | 8 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | 904 | $ | 933 | $ | 1,038 | $ | (1,971 | ) | $ | 904 | |||||||||
|
|
|
|
|
|
|
|
|
|
Parent |
All Other |
|||||||||||||||||||
(Amounts in millions) |
Guarantor |
Issuer |
Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Net income |
$ | 149 | $ | 157 | $ | 201 | $ | (328 | ) | $ | 179 | |||||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
(1,010 | ) | (1,010 | ) | (1,051 | ) | 2,020 | (1,051 | ) | |||||||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
— | — | — | — | — | |||||||||||||||
Derivatives qualifying as hedges |
(236 | ) | (236 | ) | (237 | ) | 473 | (236 | ) | |||||||||||
Foreign currency translation and other adjustments |
(5 | ) | (5 | ) | (5 | ) | 10 | (5 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other comprehensive income (loss) |
(1,251 | ) | (1,251 | ) | (1,293 | ) | 2,503 | (1,292 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive loss |
(1,102 | ) | (1,094 | ) | (1,092 | ) | 2,175 | (1,113 | ) | |||||||||||
Less: comprehensive loss attributable to noncontrolling interests |
— | — | (11 | ) | — | (11 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive loss available to Genworth Financial, Inc.’s common stockholders |
$ | (1,102 | ) | $ | (1,094 | ) | $ | (1,081 | ) | $ | 2,175 | $ | (1,102 | ) | ||||||
|
|
|
|
|
|
|
|
|
|
Parent |
All Other |
|||||||||||||||||||
(Amounts in millions) |
Guarantor |
Issuer |
Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Net income |
$ | 904 | $ | 933 | $ | 1,079 | $ | (1,971 | ) | $ | 945 | |||||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
(334 | ) | (335 | ) | (371 | ) | 670 | (370 | ) | |||||||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
6 | 6 | 6 | (12 | ) | 6 | ||||||||||||||
Derivatives qualifying as hedges |
(186 | ) | (186 | ) | (215 | ) | 401 | (186 | ) | |||||||||||
Foreign currency translation and other adjustments |
(24 | ) | (24 | ) | 149 | 47 | 148 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other comprehensive income (loss) |
(538 | ) | (539 | ) | (431 | ) | 1,106 | (402 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive income |
366 | 394 | 648 | (865 | ) | 543 | ||||||||||||||
Less: comprehensive income attributable to noncontrolling interests |
— | — | 177 | — | 177 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders |
$ | 366 | $ | 394 | $ | 471 | $ | (865 | ) | $ | 366 | |||||||||
|
|
|
|
|
|
|
|
|
|
Parent |
All Other |
|||||||||||||||||||
(Amounts in millions) |
Guarantor |
Issuer |
Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Cash flows from (used by) operating activities: |
||||||||||||||||||||
Net income |
$ | 149 | $ | 157 | $ | 201 | $ | (328 | ) | $ | 179 | |||||||||
Less loss from discontinued operations, net of taxes |
— | 2 | — | — | 2 | |||||||||||||||
Adjustments to reconcile net income to net cash from (used by) operating activities: |
||||||||||||||||||||
Equity in income from subsidiaries |
(156 | ) | (172 | ) | — | 328 | — | |||||||||||||
Amortization of fixed maturity securities discounts and premiums |
— | 1 | (35 | ) | — | (34 | ) | |||||||||||||
Net investment (gains) losses |
— | — | (28 | ) | — | (28 | ) | |||||||||||||
Charges assessed to policyholders |
— | — | (150 | ) | — | (150 | ) | |||||||||||||
Acquisition costs deferred |
— | — | (2 | ) | — | (2 | ) | |||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 92 | — | 92 | |||||||||||||||
Deferred income taxes |
1 | 44 | 12 | — | 57 | |||||||||||||||
Derivative instruments, limited partnerships and other |
— | 3 | (108 | ) | — | (105 | ) | |||||||||||||
Stock-based compensation expense |
7 | — | 3 | — | 10 | |||||||||||||||
Change in certain assets and liabilities: |
||||||||||||||||||||
Accrued investment income and other assets |
5 | 2 | (50 | ) | — | (43 | ) | |||||||||||||
Insurance reserves |
— | — | 249 | — | 249 | |||||||||||||||
Current tax liabilities |
29 | (20 | ) | (9 | ) | — | — | |||||||||||||
Other liabilities, policy and contract claims and other policy-related balances |
3 | — | (292 | ) | — | (289 | ) | |||||||||||||
Cash used by operating activities—discontinued operations |
— | (30 | ) | — | — | (30 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) operating activities |
38 | (13 | ) | (117 | ) | — | (92 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) investing activities: |
||||||||||||||||||||
Proceeds from maturities and repayments of investments: |
||||||||||||||||||||
Fixed maturity securities |
— | — | 730 | — | 730 | |||||||||||||||
Commercial mortgage loans |
— | — | 115 | — | 115 | |||||||||||||||
Limited partnerships and other invested assets |
— | — | 51 | — | 51 | |||||||||||||||
Proceeds from sales of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | 581 | — | 581 | |||||||||||||||
Purchases and originations of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | (969 | ) | — | (969 | ) | |||||||||||||
Commercial mortgage loans |
— | — | (197 | ) | — | (197 | ) | |||||||||||||
Limited partnerships and other invested assets |
— | — | (137 | ) | — | (137 | ) | |||||||||||||
Short-term investments, net |
— | (50 | ) | — | — | (50 | ) | |||||||||||||
Policy loans, net |
— | — | 14 | — | 14 | |||||||||||||||
Intercompany notes receivable, net |
(16 | ) | (56 | ) | — | 72 | — | |||||||||||||
Capital contributions to subsidiaries |
(2 | ) | (6 | ) | 8 | — | — | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) investing activities |
(18 | ) | (112 | ) | 196 | 72 | 138 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) financing activities: |
||||||||||||||||||||
Deposits to universal life and investment contracts |
— | — | 159 | — | 159 | |||||||||||||||
Withdrawals from universal life and investment contracts |
— | — | (418 | ) | — | (418 | ) | |||||||||||||
Repayment and repurchase of long-term debt |
— | (82 | ) | — | — | (82 | ) | |||||||||||||
Intercompany notes payable, net |
(12 | ) | 16 | 68 | (72 | ) | — | |||||||||||||
Other, net |
(8 | ) | — | 23 | — | 15 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash used by financing activities |
(20 | ) | (66 | ) | (168 | ) | (72 | ) | (326 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net change in cash, cash equivalents and restricted cash |
— | (191 | ) | (89 | ) | — | (280 | ) | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
— | 331 | 1,240 | — | 1,571 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash at end of period |
— | 140 | 1,151 | — | 1,291 | |||||||||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | — | $ | 140 | $ | 1,151 | $ | — | $ | 1,291 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Parent |
All Other |
|||||||||||||||||||
(Amounts in millions) |
Guarantor |
Issuer |
Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Cash flows from (used by) operating activities: |
||||||||||||||||||||
Net income |
$ | 904 | $ | 933 | $ | 1,079 | $ | (1,971 | ) | $ | 945 | |||||||||
Less income from discontinued operations, net of taxes |
— | (13 | ) | (14 | ) | — | (27 | ) | ||||||||||||
Adjustments to reconcile net income to net cash from (used by) operating activities: |
||||||||||||||||||||
Equity in income from subsidiaries |
(930 | ) | (1,041 | ) | — | 1,971 | — | |||||||||||||
Dividends from subsidiaries |
— | 552 | (552 | ) | — | — | ||||||||||||||
Amortization of fixed maturity securities discounts and premiums |
— | 6 | (182 | ) | — | (176 | ) | |||||||||||||
Net investment (gains) losses |
— | — | (323 | ) | — | (323 | ) | |||||||||||||
Charges assessed to policyholders |
— | — | (620 | ) | — | (620 | ) | |||||||||||||
Acquisition costs deferred |
— | — | (8 | ) | — | (8 | ) | |||||||||||||
Amortization of deferred acquisition costs and intangibles |
— | — | 377 | — | 377 | |||||||||||||||
Deferred income taxes |
— | 341 | (51 | ) | — | 290 | ||||||||||||||
Derivative instruments, limited partnerships and other |
— | 75 | (434 | ) | — | (359 | ) | |||||||||||||
Stock-based compensation expense |
40 | — | — | — | 40 | |||||||||||||||
Change in certain assets and liabilities: |
||||||||||||||||||||
Accrued investment income and other assets |
(1 | ) | 9 | (137 | ) | — | (129 | ) | ||||||||||||
Insurance reserves |
— | — | 642 | — | 642 | |||||||||||||||
Current tax liabilities |
(5 | ) | 17 | (46 | ) | — | (34 | ) | ||||||||||||
Other liabilities, policy and contract claims and other policy-related balances |
(13 | ) | (40 | ) | 363 | — | 310 | |||||||||||||
Cash from (used by) operating activities—discontinued operations |
— | (564 | ) | 73 | — | (491 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) operating activities |
(5 | ) | 275 | 167 | — | 437 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) investing activities: |
||||||||||||||||||||
Proceeds from maturities and repayments of investments: |
||||||||||||||||||||
Fixed maturity securities |
— | — | 4,162 | — | 4,162 | |||||||||||||||
Commercial mortgage loans |
— | — | 874 | — | 874 | |||||||||||||||
Limited partnerships and other invested assets |
— | — | 255 | — | 255 | |||||||||||||||
Proceeds from sales of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | 2,273 | — | 2,273 | |||||||||||||||
Purchases and originations of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— | — | (5,216 | ) | — | (5,216 | ) | |||||||||||||
Commercial mortgage loans |
— | — | (963 | ) | — | (963 | ) | |||||||||||||
Limited partnerships and other invested assets |
— | — | (767 | ) | — | (767 | ) | |||||||||||||
Short-term investments, net |
— | — | 18 | — | 18 | |||||||||||||||
Policy loans, net |
— | — | 57 | — | 57 | |||||||||||||||
Intercompany notes receivable, net |
— | 4 | (1 | ) | (3 | ) | — | |||||||||||||
Capital contributions to subsidiaries |
(2 | ) | — | 2 | — | — | ||||||||||||||
Proceeds from sale of business, net of cash transferred |
— | — | 270 | — | 270 | |||||||||||||||
Cash used by investing activities—discontinued operations |
— | — | (67 | ) | — | (67 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) investing activities |
(2 | ) | 4 | 897 | (3 | ) | 896 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash flows from (used by) financing activities: |
||||||||||||||||||||
Deposits to universal life and investment contracts |
— | — | 669 | — | 669 | |||||||||||||||
Withdrawals from universal life and investment contracts |
— | — | (2,071 | ) | — | (2,071 | ) | |||||||||||||
Repayment and repurchase of long-term debt |
— | (1,541 | ) | — | — | (1,541 | ) | |||||||||||||
Intercompany notes payable, net |
12 | 1 | (16 | ) | 3 | — | ||||||||||||||
Proceeds from sale of subsidiary shares to noncontrolling interests |
— | 529 | — | — | 529 | |||||||||||||||
Dividends paid to noncontrolling interests |
— | — | (37 | ) | — | (37 | ) | |||||||||||||
Other, net |
(5 | ) | (15 | ) | 52 | — | 32 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net cash from (used by) financing activities |
7 | (1,026 | ) | (1,403 | ) | 3 | (2,419 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $(1) related to discontinued operations) |
— | — | 1 | — | 1 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net change in cash, cash equivalents and restricted cash |
— | (747 | ) | (338 | ) | — | (1,085 | ) | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
— | 1,078 | 1,578 | — | 2,656 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash at end of period |
— | 331 | 1,240 | — | 1,571 | |||||||||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | — | $ | 331 | $ | 1,240 | $ | — | $ | 1,571 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Item |
1. Legal Proceedings |
Item |
1A. Risk Factors |
Number |
Description | |
31.1 | Certification of Thomas J. McInerney (filed herewith) | |
31.2 | Certification of Daniel J. Sheehan IV (filed herewith) | |
32.1 | Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code— Thomas J. McInerney (filed herewith) | |
32.2 | Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code— Daniel J. Sheehan IV (filed herewith) | |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101) |
GENWORTH FINANCIAL, INC. (Registrant) | ||||
Date: May 5, 2022 | ||||
By: | /s/ Jerome T. Upton | |||
Jerome T. Upton Senior Vice President and Controller (Principal Accounting Officer) |